{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T22:24:54Z","timestamp":1793744694656,"version":"4.6.1"},"reference-count":357,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006751","name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Salud Mental","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006751","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020668","name":"European Research Executive Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020668","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1U01MH124639\\u201301"],"award-info":[{"award-number":["1U01MH124639\\u201301"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5P50MH115846\\u201303"],"award-info":[{"award-number":["5P50MH115846\\u201303"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["RP-PG-0618-20003"],"award-info":[{"award-number":["RP-PG-0618-20003"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["NIHR303122"],"award-info":[{"award-number":["NIHR303122"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["101095568-HORIZONHLTH- 2022-DISEASE-07-03"],"award-info":[{"award-number":["101095568-HORIZONHLTH- 2022-DISEASE-07-03"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["NIHR130077"],"award-info":[{"award-number":["NIHR130077"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["NIHR203035"],"award-info":[{"award-number":["NIHR203035"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["NIHR128472"],"award-info":[{"award-number":["NIHR128472"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["NIHR203684"],"award-info":[{"award-number":["NIHR203684"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["PMP21\/00051"],"award-info":[{"award-number":["PMP21\/00051"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["PI19\/01024"],"award-info":[{"award-number":["PI19\/01024"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008062","name":"Fundaci\u00f3n Alicia Koplowitz","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007332","name":"Autism Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007332","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","award":["101034377"],"award-info":[{"award-number":["101034377"]}],"id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","award":["777394"],"award-info":[{"award-number":["777394"]}],"id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","award":["AIMS-2-TRIALS"],"award-info":[{"award-number":["AIMS-2-TRIALS"]}],"id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018693","name":"HORIZON EUROPE Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.pnpbp.2024.111176","type":"journal-article","created":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T07:23:38Z","timestamp":1730100218000},"page":"111176","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["The pediatric psychopharmacology of autism spectrum disorder: A systematic review - Part II: The future"],"prefix":"10.1016","volume":"136","author":[{"given":"Antonio M.","family":"Persico","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Asta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fethia","family":"Chehbani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvestro","family":"Mirabelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Parlatini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuele","family":"Cortese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celso","family":"Arango","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedetto","family":"Vitiello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.pnpbp.2024.111176_bib1767","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1089\/acm.2004.10.1033","article-title":"Pilot study of a moderate dose multivitamin\/mineral supplement for children with autistic spectrum disorder","volume":"10","author":"Adams","year":"2004","journal-title":"J. Altern. Complement. Med."},{"key":"10.1016\/j.pnpbp.2024.111176_bb0005","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.neulet.2007.05.025","article-title":"Preliminary evidence for involvement of the folate gene polymorphism 19bp deletion-DHFR in occurrence of autism","volume":"422","author":"Adams","year":"2007","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pnpbp.2024.111176_bib1766","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/1471-2431-11-111","article-title":"Effect of a vitamin\/mineral supplement on children and adults with autism","volume":"11","author":"Adams","year":"2011","journal-title":"BMC pediatrics"},{"key":"10.1016\/j.pnpbp.2024.111176_bb0010","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1472-6904-9-17","article-title":"Safety and efficacy of oral DMSA therapy for children with autism spectrum disorders: part B - behavioral results","volume":"9","author":"Adams","year":"2009","journal-title":"BMC Clin. Pharmacol."},{"key":"10.1016\/j.pnpbp.2024.111176_bb0015","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1472-6904-9-16","article-title":"Safety and efficacy of oral DMSA therapy for children with autism spectrum disorders: Part A--medical results","volume":"9","author":"Adams","year":"2009","journal-title":"BMC Clin. Pharmacol."},{"key":"10.1016\/j.pnpbp.2024.111176_bb0020","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1471-230X-11-22","article-title":"Gastrointestinal flora and gastrointestinal status in children with autism\u2013comparisons to typical children and correlation with autism severity","volume":"11","author":"Adams","year":"2011","journal-title":"BMC Gastroenterol."},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111176_bb0025","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3390\/nu10030369","article-title":"Comprehensive Nutritional and Dietary Intervention for Autism Spectrum Disorder-A Randomized, Controlled 12-Month Trial","volume":"10","author":"Adams","year":"2018","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111176_bb0030","first-page":"91","article-title":"Vitamin D3 Supplementation and Aquatic Exercise Combination as a Safe- Efficient Therapeutic Strategy to Ameliorate Interleukin-6 and 10, and Social Interaction in Children with Autism","volume":"18","author":"Adibsaber","year":"2024","journal-title":"Iran J. Child Neurol."},{"issue":"9","key":"10.1016\/j.pnpbp.2024.111176_bb0035","first-page":"1556","article-title":"Statins in Children with Neurofibromatosis Type 1: A Systematic Review of Randomized Controlled Trials","volume":"10","author":"Agouridis","year":"2023","journal-title":"Children (Basel)"},{"key":"10.1016\/j.pnpbp.2024.111176_bb0040","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1002\/jnr.21918","article-title":"Activation and reversal of lipotoxicity in PC 12 and rat cortical cells following exposure to palmitic acid","volume":"87","author":"Almaguel","year":"2009","journal-title":"J. Neurosci. Res."},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111176_bb0045","doi-asserted-by":"crossref","first-page":"252","DOI":"10.3109\/1354750X.2010.548010","article-title":"Urinary p-cresol is elevated in small children with severe autism spectrum disorder","volume":"16","author":"Altieri","year":"2011","journal-title":"Biomarkers"},{"issue":"5","key":"10.1016\/j.pnpbp.2024.111176_bb0050","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1089\/cap.2015.0146","article-title":"Safety and efficacy of Memantine in children with autism: randomized, placebo-controlled study and open-label extension","volume":"27","author":"Aman","year":"2017","journal-title":"J. Child Adolesc. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.pnpbp.2024.111176_bb0055","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1089\/cap.2017.0072","article-title":"Effects of metformin on spatial and verbal memory in children with ASD and overweight associated with atypical antipsychotic use","volume":"28","author":"Aman","year":"2018","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2024.111176_bb0060","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.tins.2007.12.005","article-title":"Neuroanatomy of autism","volume":"31","author":"Amaral","year":"2008","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.pnpbp.2024.111176_bb0065","series-title":"Diagnostic and Statistical Manual of Psychiatric Disorders. 5th edition, text revision","author":"American Psychiatric Association","year":"2022"},{"issue":"4","key":"10.1016\/j.pnpbp.2024.111176_bb0070","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.biopsych.2006.05.007","article-title":"Omega-3 fatty acids supplementation in children with autism: a double-blind randomized, placebo-controlled pilot study","volume":"61","author":"Amminger","year":"2007","journal-title":"Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.pnpbp.2024.111176_bb0075","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/WCO.0000000000000542","article-title":"Clinical trials in autism spectrum disorder: evidence, challenges and future directions","volume":"31","author":"Anagnostou","year":"2018","journal-title":"Curr. Opin. Neurol."},{"issue":"9","key":"10.1016\/j.pnpbp.2024.111176_bb0080","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1001\/jamapsychiatry.2016.1232","article-title":"Metformin for treatment of overweight induced by atypical antipsychotic medication in Young people with autism Spectrum disorder: a randomized clinical trial [published correction appears in JAMA psychiatry. 2016 Dec 1;73(12):1295]","volume":"73","author":"Anagnostou","year":"2016","journal-title":"JAMA Psychiatr."},{"issue":"4","key":"10.1016\/j.pnpbp.2024.111176_bb0085","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.neuron.2018.12.026","article-title":"Increased Excitation-Inhibition Ratio Stabilizes Synapse and Circuit Excitability in Four Autism Mouse Models","volume":"101","author":"Antoine","year":"2019","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111176_bb0090","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13229-021-00420-2","article-title":"Cannabinoid treatment for autism: a proof-of-concept randomized trial","volume":"12","author":"Aran","year":"2021","journal-title":"Mol Autism."},{"key":"10.1016\/j.pnpbp.2024.111176_bb0095","series-title":"Available on the Web site of the European College of NeuroPsychopharmacology (ECNP)","article-title":"It is not all about the lack of positive clinical trials. Message from the President","author":"Arango","year":"2017"},{"key":"10.1016\/j.pnpbp.2024.111176_bb0100","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1097\/00004583-200312000-00011","article-title":"Parent-defined target symptoms respond to risperidone in RUPP autism study: customer approach to clinical trials","volume":"42","author":"Arnold","year":"2003","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111176_bb0105","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1089\/cap.2011.0056","article-title":"Placebo-controlled pilot trial of mecamylamine for treatment of autism spectrum disorders","volume":"22","author":"Arnold","year":"2012","journal-title":"J. Child Adolesc. Psychopharmacol."},{"issue":"9","key":"10.1016\/j.pnpbp.2024.111176_bb0110","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1089\/cap.2018.0156","article-title":"Probiotics for gastrointestinal symptoms and quality of life in autism: a placebo-controlled pilot trial","volume":"29","author":"Arnold","year":"2019","journal-title":"J. Child Adolesc. Psychopharmacol."},{"issue":"5","key":"10.1016\/j.pnpbp.2024.111176_bb0115","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/WNF.0000000000000405","article-title":"Does Pregnenolone adjunct to risperidone ameliorate irritable behavior in adolescents with autism Spectrum disorder: a randomized, double-blind, placebo-controlled clinical trial?","volume":"43","author":"Ayatollahi","year":"2020","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.pnpbp.2024.111176_bb0120","doi-asserted-by":"crossref","first-page":"9134","DOI":"10.1523\/JNEUROSCI.22-20-09134.2002","article-title":"The origin and neuronal function of in vivo nonsynaptic glutamate","volume":"22","author":"Baker","year":"2002","journal-title":"J. Neurosci."},{"issue":"5","key":"10.1016\/j.pnpbp.2024.111176_bb0125","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1007\/s10578-020-01072-8","article-title":"Folinic acid as adjunctive therapy in treatment of inappropriate speech in children with autism: a double-blind and placebo-controlled randomized trial","volume":"52","author":"Batebi","year":"2021","journal-title":"Child Psychiatry Hum. Dev."},{"key":"10.1016\/j.pnpbp.2024.111176_bb0130","series-title":"The Neurobiology of Autism","year":"2005"},{"issue":"2","key":"10.1016\/j.pnpbp.2024.111176_bb0135","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/brb3.208","article-title":"N-acetylcysteine (NAC) in neurological disorders: mechanisms of action and therapeutic opportunities","volume":"4","author":"Bavarsad Shahripour","year":"2014","journal-title":"Brain Behav."},{"issue":"10","key":"10.1016\/j.pnpbp.2024.111176_bb0140","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1080\/15563650701261488","article-title":"Pediatric fatality secondary to EDTA chelation","volume":"46","author":"Baxter","year":"2008","journal-title":"Clin. Toxicol. (Phila.)"},{"key":"10.1016\/j.pnpbp.2024.111176_bb0145","doi-asserted-by":"crossref","first-page":"3","DOI":"10.20517\/rdodj.2023.36","article-title":"Management of sleep problems in people with autism: an updated review","volume":"3","author":"Bellato","year":"2024","journal-title":"Rare Dis. Orphan. Drugs J."},{"issue":"42","key":"10.1016\/j.pnpbp.2024.111176_bb0150","doi-asserted-by":"crossref","first-page":"9228","DOI":"10.1523\/JNEUROSCI.3340-04.2004","article-title":"Autism and abnormal development of brain connectivity","volume":"24","author":"Belmonte","year":"2004","journal-title":"J. Neurosci."},{"issue":"9","key":"10.1016\/j.pnpbp.2024.111176_bb0155","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.tins.2017.07.001","article-title":"NKCC1 chloride importer antagonists attenuate many neurological and psychiatric disorders","volume":"40","author":"Ben-Ari","year":"2017","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.pnpbp.2024.111176_bb0160","doi-asserted-by":"crossref","first-page":"2","DOI":"10.20517\/rdodj.2023.22","article-title":"Bumetanide to treat autism spectrum disorders: are complex administrative regulations fit to treat heterogeneous disorders?","volume":"3","author":"Ben-Ari","year":"2024","journal-title":"Rare Dis. Orphan. Drugs J."},{"key":"10.1016\/j.pnpbp.2024.111176_bb0165","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0079-6123(08)60545-2","article-title":"Gamma-aminobutyric acid (GABA): a fast excitatory transmitter which may regulate the development of hippocampal neurones in early postnatal life","volume":"102","author":"Ben-Ari","year":"1994","journal-title":"Prog. Brain Res."},{"issue":"4","key":"10.1016\/j.pnpbp.2024.111176_bb0170","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1152\/physrev.00017.2006","article-title":"GABA: a pioneer transmitter that excites immature neurons and generates primitive oscillations","volume":"87","author":"Ben-Ari","year":"2007","journal-title":"Physiol. Rev."},{"issue":"5","key":"10.1016\/j.pnpbp.2024.111176_bb0175","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1177\/1073858412438697","article-title":"The GABA excitatory\/inhibitory shift in brain maturation and neurological disorders","volume":"18","author":"Ben-Ari","year":"2012","journal-title":"Neuroscientist"},{"issue":"5","key":"10.1016\/j.pnpbp.2024.111176_bb0180","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s10803-010-1078-8","article-title":"A pilot randomized controlled trial of omega-3 fatty acids for autism spectrum disorder","volume":"41","author":"Bent","year":"2011","journal-title":"J. Autism Dev. Disord."},{"issue":"6","key":"10.1016\/j.pnpbp.2024.111176_bb0185","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.jaac.2014.01.018","article-title":"Internet-based, randomized, controlled trial of omega-3 fatty acids for hyperactivity in autism","volume":"53","author":"Bent","year":"2014","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.pnpbp.2024.111176_bb0190","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.biopsych.2008.03.004","article-title":"N-acetyl cysteine as a glutathione precursor for schizophrenia--a double-blind, randomized, placebo-controlled trial","volume":"64","author":"Berk","year":"2008","journal-title":"Biol. Psychiatry"},{"issue":"6","key":"10.1016\/j.pnpbp.2024.111176_bib1763","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.biopsych.2008.04.022","article-title":"N-acetyl cysteine for depressive symptoms in bipolar disorder--a double-blind randomized placebo-controlled trial","volume":"64","author":"Berk","year":"2008","journal-title":"Biological psychiatry"},{"key":"10.1016\/j.pnpbp.2024.111176_bb0195","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s11689-016-9181-6","article-title":"Arbaclofen in fragile X syndrome: results of phase 3 trials","volume":"9","author":"Berry-Kravis","year":"2017","journal-title":"J. Neurodev. Disord."},{"issue":"5","key":"10.1016\/j.pnpbp.2024.111176_bb0200","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1089\/acm.2009.0177","article-title":"Pilot study of the effect of methyl B12 treatment on behavioral and biomarker measures in children with autism","volume":"16","author":"Bertoglio","year":"2010","journal-title":"J. Altern. Complement. Med."},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111176_bb0205","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00213-023-06452-1","article-title":"Randomized controlled trial of propranolol on social communication and anxiety in children and young adults with autism spectrum disorder","volume":"241","author":"Beversdorf","year":"2024","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2024.111176_bb0210","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1078\/0944-5013-00192","article-title":"Screening of Bifidobacterium strains isolated from human faeces for antagonistic activities against potentially bacterial pathogens","volume":"158","author":"Bevilacqua","year":"2003","journal-title":"Microbiol. Res."},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111176_bb0215","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/sj.npp.1300360","article-title":"Profound impairment in social recognition and reduction in anxiety-like behavior in vasopressin V1a receptor knockout mice","volume":"29","author":"Bielsky","year":"2004","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111176_bb0220","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1177\/13623613221082710","article-title":"A randomized controlled trial into the effects of probiotics on electroencephalography in preschoolers with autism","volume":"27","author":"Billeci","year":"2023","journal-title":"Autism"},{"issue":"2","key":"10.1016\/j.pnpbp.2024.111176_bb0225","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1136\/jmg.2008.061796","article-title":"Minocycline promotes dendritic spine maturation and improves behavioural performance in the fragile X mouse model","volume":"46","author":"Bilousova","year":"2009","journal-title":"J. Med. Genet."},{"issue":"491","key":"10.1016\/j.pnpbp.2024.111176_bb0230","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aat7838","article-title":"A phase 2 clinical trial of a vasopressin V1a receptor antagonist shows improved adaptive behaviors in men with autism spectrum disorder","volume":"11","author":"Bolognani","year":"2019","journal-title":"Sci. Transl. Med."},{"issue":"4","key":"10.1016\/j.pnpbp.2024.111176_bb0235","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1192\/bjp.bp.109.076877","article-title":"Epilepsy in autism: features and correlates","volume":"198","author":"Bolton","year":"2011","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2024.111176_bb0240","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.molmed.2014.05.002","article-title":"Microbiota and neurodevelopmental windows: implications for brain disorders","volume":"20","author":"Borre","year":"2014","journal-title":"Trends Mol. Med."},{"issue":"8","key":"10.1016\/j.pnpbp.2024.111176_bb0245","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/nbt0898-728","article-title":"Nutraceuticals: poised for a healthy slice of the healthcare market?","volume":"16","author":"Brower","year":"1998","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.pnpbp.2024.111176_bb0250","series-title":"Nicotinic Receptors in the Nervous System. Edited by E. Levin","article-title":"Nicotine and cognition in young and aged nonhuman primates","author":"Buccafusco","year":"2002"},{"issue":"2","key":"10.1016\/j.pnpbp.2024.111176_bb0255","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/dmcn.14005","article-title":"Grandbois van Ravenhorst C, et al. effect of continuous intrathecal baclofen therapy in children: a systematic review","volume":"61","author":"Buizer","year":"2019","journal-title":"Dev. Med. Child Neurol."},{"issue":"4","key":"10.1016\/j.pnpbp.2024.111176_bb0260","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1111\/j.1471-4159.2004.02520.x","article-title":"Docosahexaenoic acid promotes neurite growth in hippocampal neurons","volume":"90","author":"Calderon","year":"2004","journal-title":"J. Neurochem."},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111176_bb0265","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1023\/A:1015493412224","article-title":"Double-blind placebo-controlled trial of secretin: effects on aberrant behavior in children with autism","volume":"32","author":"Carey","year":"2002","journal-title":"J. Autism Dev. Disord."},{"issue":"8","key":"10.1016\/j.pnpbp.2024.111176_bb0270","first-page":"204","article-title":"Deaths associated with hypocalcemia from chelation therapy--Texas, Pennsylvania, and Oregon, 2003\u20132005","volume":"55","author":"Centers for Disease Control and Prevention (CDC)","year":"2006","journal-title":"MMWR Morb. Mortal Wkly. Rep."},{"issue":"4","key":"10.1016\/j.pnpbp.2024.111176_bb0275","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s13311-015-0371-9","article-title":"Endocannabinoid Signaling in Autism","volume":"12","author":"Chakrabarti","year":"2015","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.pnpbp.2024.111176_bb0280","doi-asserted-by":"crossref","first-page":"4427","DOI":"10.1523\/JNEUROSCI.12-11-04427.1992","article-title":"Openchannel block of N-methyl-D-aspartate (NMDA) responses by memantine: therapeutic advantage against NMDA receptor-mediated neurotoxicity","volume":"12","author":"Chen","year":"1992","journal-title":"J. Neurosci."},{"issue":"Pt 5","key":"10.1016\/j.pnpbp.2024.111176_bb0285","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1093\/brain\/awv051","article-title":"Autism: reduced connectivity between cortical areas involved in face expression, theory of mind, and the sense of self","volume":"138","author":"Cheng","year":"2015","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.pnpbp.2024.111176_bb0290","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1023\/A:1005443119324","article-title":"Secretin and autism: a two-part clinical investigation","volume":"30","author":"Chez","year":"2000","journal-title":"J. Autism Dev. Disord."},{"issue":"11","key":"10.1016\/j.pnpbp.2024.111176_bb0295","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1177\/08830738020170111501","article-title":"Double-blind, placebo-controlled study of L-carnosine supplementation in children with autistic spectrum disorders","volume":"17","author":"Chez","year":"2002","journal-title":"J. Child Neurol."},{"issue":"5","key":"10.1016\/j.pnpbp.2024.111176_bb0300","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1007\/s10803-018-3703-x","article-title":"A randomized, placebo-controlled, blinded, crossover, pilot study of the effects of dextromethorphan\/quinidine for the treatment of neurobehavioral symptoms in adults with autism","volume":"50","author":"Chez","year":"2020","journal-title":"J. Autism Dev. Disord."},{"issue":"8","key":"10.1016\/j.pnpbp.2024.111176_bb0305","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1001\/archpsyc.55.8.708","article-title":"Cerebrospinal fluid vasopressin levels: correlates with aggression and serotonin function in personality-disordered subjects","volume":"55","author":"Coccaro","year":"1998","journal-title":"Arch. Gen. Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111176_bb0310","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s12888-023-04695-y","article-title":"Role of cortical excitatory\/inhibitory imbalance in autism spectrum disorders from a symptom severity trajectories framework: a study protocol","volume":"23","author":"Colomar","year":"2023","journal-title":"BMC Psychiatr."},{"issue":"5","key":"10.1016\/j.pnpbp.2024.111176_bb0315","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1067\/mpd.2001.112474","article-title":"A randomized, double-blind, placebo-controlled trial of single-dose intravenous secretin as treatment for children with autism","volume":"138","author":"Coniglio","year":"2001","journal-title":"J. Pediatr."},{"issue":"8","key":"10.1016\/j.pnpbp.2024.111176_bb0320","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1136\/adc.88.8.737","article-title":"Children with autistic spectrum disorders. II: parents are unable to distinguish secretin from placebo under double-blind conditions","volume":"88","author":"Coplan","year":"2003","journal-title":"Arch. Dis. Child."},{"issue":"6","key":"10.1016\/j.pnpbp.2024.111176_bb0325","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1177\/000992280104000604","article-title":"A double-blind, placebo-controlled crossover study investigating the effect of porcine secretin in children with autism","volume":"40","author":"Corbett","year":"2001","journal-title":"Clin. Pediatr. (Phila)"},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111176_bb0330","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/wps.21037","article-title":"Candidate diagnostic biomarkers for neurodevelopmental disorders in children and adolescents: a systematic review","volume":"22","author":"Cortese","year":"2023","journal-title":"World Psychiatry"},{"key":"10.1016\/j.pnpbp.2024.111176_bb0335","doi-asserted-by":"crossref","first-page":"105149","DOI":"10.1016\/j.neubiorev.2023.105149","article-title":"The future of child and adolescent clinical psychopharmacology: a systematic review of phase 2, 3, or 4 randomized controlled trials of pharmacologic agents without regulatory approval or for unapproved indications","volume":"149","author":"Cortese","year":"2023","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"2","key":"10.1016\/j.pnpbp.2024.111176_bb0340","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S2215-0366(23)00345-0","article-title":"Psychopharmacology in children and adolescents: unmet needs and opportunities","volume":"11","author":"Cortese","year":"2024","journal-title":"Lancet Psychiatry"},{"issue":"2","key":"10.1016\/j.pnpbp.2024.111176_bb0345","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.conb.2005.03.001","article-title":"Why the frontal cortex in autism might be talking only to itself: local over-connectivity but long-distance disconnection","volume":"15","author":"Courchesne","year":"2005","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.pnpbp.2024.111176_bb0350","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2011\/161358","article-title":"The potential role of probiotics in the management of childhood autism spectrum disorders","volume":"2011","author":"Critchfield","year":"2011","journal-title":"Gastroenterol. Res. Pract."},{"key":"10.1016\/j.pnpbp.2024.111176_bb0355","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.2174\/09298673113209990140","article-title":"N-3 fatty acids: role in neurogenesis and neuroplasticity","volume":"20","author":"Crupi","year":"2013","journal-title":"Curr. Med. Chem."},{"issue":"8","key":"10.1016\/j.pnpbp.2024.111176_bb0360","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1007\/s10803-020-04709-8","article-title":"Bumetanide Oral Liquid Formulation for the Treatment of Children and Adolescents with Autism Spectrum Disorder: Design of Two Phase III Studies (SIGN Trials) [published correction appears in J Autism Dev Disord. 2021 Jan 9;:]","volume":"51","author":"Crutel","year":"2021","journal-title":"J. Autism Dev. Disord."},{"key":"10.1016\/j.pnpbp.2024.111176_bb0365","doi-asserted-by":"crossref","first-page":"829516","DOI":"10.3389\/fpsyt.2022.829516","article-title":"Efficacy and Safety of Q10 Ubiquinol With Vitamins B and E in Neurodevelopmental Disorders: A Retrospective Chart Review","volume":"13","author":"Cucinotta","year":"2022","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.pnpbp.2024.111176_bb0370","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/phar.1920","article-title":"Effectiveness of sleep-based interventions for children with autism Spectrum disorder: a Meta-synthesis","volume":"37","author":"Cuomo","year":"2017","journal-title":"Pharmacotherapy"},{"issue":"15","key":"10.1016\/j.pnpbp.2024.111176_bb0375","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/j.scib.2021.01.008","article-title":"Improved symptoms following bumetanide treatment in children aged 3-6 years with autism spectrum disorder: a randomized, double-blind, placebo-controlled trial","volume":"66","author":"Dai","year":"2021","journal-title":"Sci. Bull. (Beijing)."},{"issue":"5","key":"10.1016\/j.pnpbp.2024.111176_bb0380","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/01.jcp.0000177667.35016.e9","article-title":"Tetrahydrobiopterin in the treatment of children with autistic disorder: a double-blind placebo-controlled crossover study","volume":"25","author":"Danfors","year":"2005","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2024.111176_bb0385","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1476-5381.2012.02057.x","article-title":"Alzheimer\u2019s disease, beta-amyloid, glutamate, NMDA receptors and memantine\u2014searching for the connections","volume":"167","author":"Danysz","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2024.111176_bb0390","doi-asserted-by":"crossref","first-page":"790250","DOI":"10.3389\/fnut.2022.790250","article-title":"Docosahexaenoic and Eicosapentaenoic Intervention Modifies Plasma and Erythrocyte Omega-3 Fatty Acid Profiles But Not the Clinical Course of Children With Autism Spectrum Disorder: A Randomized Control Trial","volume":"9","author":"de la Torre-Aguilar","year":"2022","journal-title":"Front. Nutr."},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111176_bb0395","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1177\/0004867416652735","article-title":"A randomised, double blind, placebo-controlled trial of a fixed dose of N-acetyl cysteine in children with autistic disorder","volume":"51","author":"Dean","year":"2017","journal-title":"Aust. N. Z. J. Psychiatr."},{"key":"10.1016\/j.pnpbp.2024.111176_bib1765","series-title":"The nutraceutical revolution: fueling a powerful, new international market. Harvard University Advanced Management Program in Biomedical Research and Development. Como, Italy","author":"DeFelice","year":"1989"},{"key":"10.1016\/j.pnpbp.2024.111176_bb0400","first-page":"309","article-title":"Cation-chloride cotransporters in neuronal communication","volume":"15","author":"Delpire","year":"2000","journal-title":"News Physiol. Sci."},{"key":"10.1016\/j.pnpbp.2024.111176_bb0405","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.it.2012.10.002","article-title":"The role of microglia in brain maintanance: implications for Rett syndrome","volume":"34","author":"Derecki","year":"2013","journal-title":"Trends Immunol."},{"key":"10.1016\/j.pnpbp.2024.111176_bb0410","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.euroneuro.2021.02.020","article-title":"A white paper on a neurodevelopmental framework for drug discovery in autism and other neurodevelopmental disorders","volume":"48","author":"D\u00edaz-Caneja","year":"2021","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111176_bb0415","doi-asserted-by":"crossref","first-page":"12","DOI":"10.5114\/pedm.2020.101806","volume":"27","author":"Doaei","year":"2021","journal-title":"Pediatr. Endocrinol. Diabetes Metab."},{"issue":"6 Suppl 4","key":"10.1016\/j.pnpbp.2024.111176_bb0420","first-page":"S233","article-title":"The pharmacology and mechanism of action of riluzole","volume":"47","author":"Doble","year":"1996","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.pnpbp.2024.111176_bb0425","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/0278-5846(93)90058-Z","article-title":"A preliminary trial of ascorbic acid as supplemental therapy for autism","volume":"17","author":"Dolske","year":"1993","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.pnpbp.2024.111176_bb0430","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/sj.npp.1301178","article-title":"The anticonvulsants lamotrigine, riluzole, and valproate differentially regulate AMPA receptor membrane localization: relationship to clinical effects in mood disorders","volume":"32","author":"Du","year":"2007","journal-title":"Neuropsychopharmacology"},{"issue":"7","key":"10.1016\/j.pnpbp.2024.111176_bb0435","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1089\/cap.2015.0045","article-title":"A pilot study on the combination of applied behavior analysis and bumetanide treatment for children with autism","volume":"25","author":"Du","year":"2015","journal-title":"J. Child Adolesc. Psychopharmacol."},{"issue":"12","key":"10.1016\/j.pnpbp.2024.111176_bb0440","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/j.1469-8749.2000.tb00692.x","article-title":"Effect of secretin on children with autism: a randomized controlled trial","volume":"42","author":"Dunn-Geier","year":"2000","journal-title":"Dev. Med. Child Neurol."},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111176_bb0445","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1097\/ALN.0b013e3181cf9138","article-title":"Bumetanide alleviates epileptogenic and neurotoxic effects of sevoflurane in neonatal rat brain","volume":"112","author":"Edwards","year":"2010","journal-title":"Anesthesiology"},{"issue":"12","key":"10.1016\/j.pnpbp.2024.111176_bb0450","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s40263-018-0571-z","article-title":"Metformin for weight gain associated with second-generation antipsychotics in children and adolescents: a systematic review and Meta-analysis","volume":"32","author":"Ellul","year":"2018","journal-title":"CNS Drugs"},{"issue":"4","key":"10.1016\/j.pnpbp.2024.111176_bb0455","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1007\/s10803-013-1963-z","article-title":"STX209 (arbaclofen) for autism spectrum disorders: an 8-week open-label study","volume":"44","author":"Erickson","year":"2014","journal-title":"J. Autism Dev. Disord."},{"key":"10.1016\/j.pnpbp.2024.111176_bb0460","article-title":"Brief report: a double-blind, placebo-controlled, crossover, proof-of-concept study of minocycline in autism spectrum disorder","volume":"15","author":"Erickson","year":"2023","journal-title":"J. Autism Dev. Disord."},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111176_bb0465","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.rasd.2012.07.006","article-title":"L-carnitine supplementation improves the behavioral symptoms in autistic children","volume":"7","author":"Fahmy","year":"2013","journal-title":"Res. Autism Spectr. Disord."},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111176_bb0470","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1111\/j.1471-4159.1986.tb00695.x","article-title":"Comparative stereostructure-activity studies on GABAA and GABAB receptor sites and GABA uptake using rat brain membrane preparations","volume":"47","author":"Falch","year":"1986","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pnpbp.2024.111176_bb0475","series-title":"Probiotics in Food. Health and Nutritional Properties and Guidelines for Evaluation. FAO Food and Nutrition Paper n. 85","author":"FAO\/WHO","year":"2006"},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111176_bb0480","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.pnpbp.2007.11.004","article-title":"The hyperglutamatergic hypothesis of autism","volume":"32","author":"Fatemi","year":"2008","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"6","key":"10.1016\/j.pnpbp.2024.111176_bb0485","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s10803-004-5283-1","article-title":"Relative carnitine deficiency in autism","volume":"34","author":"Filipek","year":"2004","journal-title":"J. Autism Dev. Disord."},{"issue":"4","key":"10.1016\/j.pnpbp.2024.111176_bb0490","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1023\/A:1025861522935","article-title":"High-dose pyridoxine and magnesium administration in children with autistic disorder: an absence of salutary effects in a double-blind, placebo-controlled study","volume":"27","author":"Findling","year":"1997","journal-title":"J. Autism Dev. Disord."},{"key":"10.1016\/j.pnpbp.2024.111176_bb0495","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.anaerobe.2010.06.008","article-title":"Pyrosequencing study of fecal microflora of autistic and control children","volume":"16","author":"Finegold","year":"2010","journal-title":"Anaerobe"},{"key":"10.1016\/j.pnpbp.2024.111176_bb0500","first-page":"5","article-title":"Quantitative real time PCR detection of Clostridium difficile growth inhibition by probiotic organisms","volume":"2","author":"Folkers","year":"2010","journal-title":"N. Am. J. Med. Sci."},{"key":"10.1016\/j.pnpbp.2024.111176_bb0505","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.patbio.2014.10.003","article-title":"The \u201cpsychomicrobiotic\u201d: targeting microbiota in major psychiatric disorders: a systematic review","volume":"63","author":"Fond","year":"2015","journal-title":"Pathol. Biol."},{"issue":"5","key":"10.1016\/j.pnpbp.2024.111176_bb0510","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2018-3218","article-title":"Dietary interventions for autism Spectrum disorder: a Meta-analysis","volume":"144","author":"Fraguas","year":"2019","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111176_bb0515","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1023\/B:CEMN.0000012717.37839.07","article-title":"Riluzole enhances glutamate uptake in rat astrocyte cultures","volume":"24","author":"Frizzo","year":"2004","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.pnpbp.2024.111176_bb0520","doi-asserted-by":"crossref","first-page":"100829","DOI":"10.1016\/j.spen.2020.100829","article-title":"Mitochondrial dysfunction in autism Spectrum disorder: unique abnormalities and targeted treatments","volume":"35","author":"Frye","year":"2020","journal-title":"Semin. Pediatr. Neurol."},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111176_bb0525","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.nurt.2010.05.004","article-title":"Tetrahydrobiopterin as a novel therapeutic intervention for autism","volume":"7","author":"Frye","year":"2010","journal-title":"Neurotherapeutics"},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111176_bb0530","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1038\/tp.2013.14","article-title":"Metabolic effects of sapropterin treatment in autism spectrum disorder: a preliminary study","volume":"3","author":"Frye","year":"2013","journal-title":"Transl. Psychiatry"},{"issue":"2","key":"10.1016\/j.pnpbp.2024.111176_bb0535","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/mp.2016.168","article-title":"Folinic acid improves verbal communication in children with autism and language impairment: a randomized double-blind placebo-controlled trial","volume":"23","author":"Frye","year":"2018","journal-title":"Mol. Psychiatry"},{"issue":"10","key":"10.1016\/j.pnpbp.2024.111176_bb0540","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1002\/aur.3005","article-title":"Bumetanide oral solution for the treatment of children and adolescents with autism spectrum disorder: results from two randomized phase III studies","volume":"16","author":"Fuentes","year":"2023","journal-title":"Autism Res."},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111176_bb0545","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.dld.2015.11.026","article-title":"Gastrointestinal symptoms and behavioral problems in preschoolers with autism Spectrum disorder","volume":"48","author":"Fulceri","year":"2016","journal-title":"Dig. Liver Dis."},{"issue":"2","key":"10.1016\/j.pnpbp.2024.111176_bb0550","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/s12031-019-01351-7","article-title":"Improvement of language in children with autism with combined donepezil and choline treatment","volume":"69","author":"Gabis","year":"2019","journal-title":"J. Mol. Neurosci."},{"issue":"7","key":"10.1016\/j.pnpbp.2024.111176_bb0555","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1002\/aur.1571","article-title":"Slow intestinal transit contributes to elevate urinary p-cresol level in Italian autistic children","volume":"9","author":"Gabriele","year":"2016","journal-title":"Autism Res."},{"key":"10.1016\/j.pnpbp.2024.111176_bb0560","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.nbd.2008.01.012","article-title":"Immune transcriptome alterations in the temporal cortex of subjects with autism","volume":"30","author":"Garbett","year":"2008","journal-title":"Neurobiol. Dis."},{"issue":"6","key":"10.1016\/j.pnpbp.2024.111176_bb0565","doi-asserted-by":"crossref","DOI":"10.12659\/MSM.881792","article-title":"A prospective double-blind, randomized clinical trial of levocarnitine to treat autism spectrum disorders","volume":"17","author":"Geier","year":"2011","journal-title":"Med. Sci. Monit."},{"issue":"5","key":"10.1016\/j.pnpbp.2024.111176_bb0570","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1007\/s10578-022-01328-5","article-title":"A phase III study of bumetanide Oral liquid formulation for the treatment of children and adolescents aged between 7 and 17 years with autism Spectrum disorder (SIGN 1 trial): participant baseline characteristics","volume":"54","author":"Georgoula","year":"2023","journal-title":"Child Psychiatry Hum. Dev."},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111176_bb0575","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.conb.2007.01.009","article-title":"Autism spectrum disorders: developmental disconnection syndromes","volume":"17","author":"Geschwind","year":"2007","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.pnpbp.2024.111176_bb0580","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13229-016-0109-5","article-title":"Urinary metabolomics of young Italian autistic children supports abnormal tryptophan and purine metabolism","volume":"7","author":"Gevi","year":"2016","journal-title":"Mol Autism."},{"issue":"4","key":"10.1016\/j.pnpbp.2024.111176_bb0585","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1017\/S1461145712000880","article-title":"Memantine as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial","volume":"16","author":"Ghaleiha","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"6","key":"10.1016\/j.pnpbp.2024.111176_bb0590","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s40272-013-0036-2","article-title":"Riluzole as an adjunctive therapy to risperidone for the treatment of irritability in children with autistic disorder: a double-blind, placebo-controlled, randomized trial","volume":"15","author":"Ghaleiha","year":"2013","journal-title":"Paediatr. Drugs"},{"issue":"7","key":"10.1016\/j.pnpbp.2024.111176_bb0595","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1177\/0269881113508830","article-title":"Galantamine efficacy and tolerability as an augmentative therapy in autistic children: a randomized, double-blind, placebo-controlled trial","volume":"28","author":"Ghaleiha","year":"2014","journal-title":"J. Psychopharmacol."},{"issue":"9","key":"10.1016\/j.pnpbp.2024.111176_bb0600","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1089\/cap.2015.0175","article-title":"Minocycline as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind placebo-controlled trial","volume":"26","author":"Ghaleiha","year":"2016","journal-title":"J. Child Adolesc. Psychopharmacol."},{"issue":"1\u20132","key":"10.1016\/j.pnpbp.2024.111176_bib1761","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.psychres.2015.07.043","article-title":"A pilot double-blind placebo-controlled trial of pioglitazone as adjunctive treatment to risperidone: Effects on aberrant behavior in children with autism","volume":"229","author":"Ghaleiha","year":"2015","journal-title":"Psychiatry research"},{"issue":"10","key":"10.1016\/j.pnpbp.2024.111176_bb0605","first-page":"985","article-title":"N-acetylcysteine for treatment of autism, a case report","volume":"17","author":"Ghanizadeh","year":"2012","journal-title":"J. Res. Med. Sci."},{"key":"10.1016\/j.pnpbp.2024.111176_bb0610","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/1471-244X-13-196","article-title":"A randomized double blind placebo controlled clinical trial of N-acetylcysteine added to risperidone for treating autistic disorders","volume":"13","author":"Ghanizadeh","year":"2013","journal-title":"BMC Psychiatr."},{"key":"10.1016\/j.pnpbp.2024.111176_bb0615","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/aur.70","article-title":"The MTHFR 677C\u2013>T polymorphism and behaviors in children with autism: exploratory genotype-phenotype correlations","volume":"2","author":"Goin-Kochel","year":"2009","journal-title":"Autism Res."},{"key":"10.1016\/j.pnpbp.2024.111176_bb0620","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1001\/archgenpsychiatry.2009.60","article-title":"N-acetylcysteine, a glutamate modulator, in the treatment of trichotillomania: a double-blind, placebo-controlled study","volume":"66","author":"Grant","year":"2009","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pnpbp.2024.111176_bb0625","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/(SICI)1097-4547(19980415)52:2<129::AID-JNR1>3.0.CO;2-C","article-title":"Mechanisms of docosahexaenoic acid accretion in the fetal brain","volume":"52","author":"Green","year":"1998","journal-title":"J. Neurosci. Res."},{"issue":"18","key":"10.1016\/j.pnpbp.2024.111176_bb0630","doi-asserted-by":"crossref","first-page":"5263","DOI":"10.3390\/jcm11185263","article-title":"Randomized Double-Blind Crossover Study for Evaluating a Probiotic Mixture on Gastrointestinal and Behavioral Symptoms of Autistic Children","volume":"11","author":"Guidetti","year":"2022","journal-title":"J. Clin. Med."},{"issue":"4","key":"10.1016\/j.pnpbp.2024.111176_bb0635","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/jnc.15604","article-title":"The metabolite p-cresol impairs dendritic development, synaptogenesis, and synapse function in hippocampal neurons: implications for autism spectrum disorder","volume":"161","author":"Guzm\u00e1n-Salas","year":"2022","journal-title":"J. Neurochem."},{"issue":"2","key":"10.1016\/j.pnpbp.2024.111176_bb0640","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1023\/A:1020521308985","article-title":"The Na-K-cl cotransporters","volume":"30","author":"Haas","year":"1998","journal-title":"J. Bioenerg. Biomembr."},{"issue":"2","key":"10.1016\/j.pnpbp.2024.111176_bb0645","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1177\/1362361313514141","article-title":"Improving emotional face perception in autism with diuretic bumetanide: a proof-of-concept behavioral and functional brain imaging pilot study","volume":"19","author":"Hadjikhani","year":"2015","journal-title":"AutismS"},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111176_bb0650","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.1038\/s41598-018-21958-x","article-title":"Bumetanide for autism: more eye contact, less amygdala activation","volume":"8","author":"Hadjikhani","year":"2018","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.pnpbp.2024.111176_bb0655","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/nn.3919","article-title":"The idiosyncratic brain: distortion of spontaneous connectivity patterns in autism spectrum disorder","volume":"18","author":"Hahamy","year":"2015","journal-title":"Nat. Neurosci."},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111176_bb0660","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1089\/cap.2017.0026","article-title":"L-Carnosine as an adjunctive therapy to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial","volume":"28","author":"Hajizadeh-Zaker","year":"2017","journal-title":"J. Child Adolesc. Psychopharmacol."},{"issue":"10","key":"10.1016\/j.pnpbp.2024.111176_bib1762","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.jaac.2017.07.790","article-title":"Veenstra-VanderWeele J. A Randomized, Placebo-Controlled Trial of Metformin for the Treatment of Overweight Induced by Antipsychotic Medication in Young People With Autism Spectrum Disorder","volume":"56","author":"Handen","year":"2017","journal-title":"Open- Label Extension. J Am Acad Child Adolesc Psychiatry."},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111176_bb0665","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1089\/cap.2010.0024","article-title":"Safety and efficacy of donepezil in children and adolescents with autism: neuropsychological measures","volume":"21","author":"Handen","year":"2011","journal-title":"J. Child Adolesc. Psychopharmacol."},{"issue":"11","key":"10.1016\/j.pnpbp.2024.111176_bb0670","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.biopsych.2012.01.014","article-title":"A randomized controlled pilot trial of oral N-acetylcysteine in children with autism","volume":"71","author":"Hardan","year":"2012","journal-title":"Biol. Psychiatry"},{"issue":"8","key":"10.1016\/j.pnpbp.2024.111176_bb0675","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1177\/1362361318824103","article-title":"Efficacy and safety of memantine in children with autism spectrum disorder: results from three phase 2 multicenter studies","volume":"23","author":"Hardan","year":"2019","journal-title":"Autism"},{"issue":"152","key":"10.1016\/j.pnpbp.2024.111176_bb0680","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3004218","article-title":"Reversal of disease-related pathologies in the fragile X mouse model by selective activation of GABAB receptors with arbaclofen","volume":"4","author":"Henderson","year":"2012","journal-title":"Sci. Transl. Med."},{"issue":"2","key":"10.1016\/j.pnpbp.2024.111176_bb0685","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/jcpt.13076","article-title":"Resveratrol as adjunctive therapy in treatment of irritability in children with autism: a double-blind and placebo-controlled randomized trial","volume":"45","author":"Hendouei","year":"2020","journal-title":"J. Clin. Pharm. Ther."},{"issue":"9","key":"10.1016\/j.pnpbp.2024.111176_bb0690","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1089\/cap.2015.0159","article-title":"Randomized, placebo-controlled trial of methyl B12 for children with autism","volume":"26","author":"Hendren","year":"2016","journal-title":"J. Child Adolesc. Psychopharmacol."},{"issue":"7927","key":"10.1016\/j.pnpbp.2024.111176_bb0695","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0140-6736(75)90672-8","article-title":"Secretin: a new role for an old hormone","volume":"2","author":"Henry","year":"1975","journal-title":"Lancet"},{"issue":"15","key":"10.1016\/j.pnpbp.2024.111176_bb0700","doi-asserted-by":"crossref","first-page":"10661","DOI":"10.1074\/jbc.274.15.10661","article-title":"Cloning, characterization, and chromosomal location of a novel human K+-cl- cotransporter","volume":"274","author":"Hiki","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.pnpbp.2024.111176_bb0705","first-page":"1639","article-title":"A pilot feasibility study assessing the combined effects of early behavioral intervention and propranolol on autism Spectrum disorder (ASD)","volume":"10","author":"Hirst","year":"2023","journal-title":"Children (Basel)."},{"issue":"8","key":"10.1016\/j.pnpbp.2024.111176_bb0710","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1001\/jamapsychiatry.2022.1717","article-title":"Balovaptan vs placebo for social communication in childhood autism Spectrum disorder: a randomized clinical trial","volume":"79","author":"Hollander","year":"2022","journal-title":"JAMA Psychiatr."},{"key":"10.1016\/j.pnpbp.2024.111176_bb0715","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3389\/fimmu.2013.00013","article-title":"Omega-3 fatty acid-derived resolvins and protectins in inflammation resolution and leukocyte functions: targeting novel lipid mediator pathways in mitigation of acute kidney injury","volume":"4","author":"Hong","year":"2013","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.pnpbp.2024.111176_bb0720","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1023\/A:1020778108068","article-title":"Secretin and sleep in children with autism","volume":"33","author":"Honomichl","year":"2002","journal-title":"Child Psychiatry Hum. Dev."},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111176_bb0725","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12991-023-00477-8","article-title":"Randomized clinical trial of low dose suramin intravenous infusions for treatment of autism spectrum disorder","volume":"22","author":"Hough","year":"2023","journal-title":"Ann. General Psychiatry"},{"issue":"10","key":"10.1016\/j.pnpbp.2024.111176_bb0730","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1007\/s00228-023-03545-w","article-title":"Oxytocin treatment for core symptoms in children with autism spectrum disorder: a systematic review and meta-analysis","volume":"79","author":"Hu","year":"2023","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.pnpbp.2024.111176_bb0735","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.neubiorev.2020.12.028","article-title":"Intranasal oxytocin in the treatment of autism spectrum disorders: a multilevel meta-analysis","volume":"122","author":"Huang","year":"2021","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.pnpbp.2024.111176_bb0740","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1023\/A:1027393724676","article-title":"Membrane fatty acid modifications of PC12 cells by arachidonate or docosahexaenoate affect neurite outgrowth but not norepinephrine release","volume":"22","author":"Ikemoto","year":"1997","journal-title":"Neurochem. Res."},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111176_bb0745","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13229-022-00505-6","article-title":"Large multicenter randomized trials in autism: key insights gained from the balovaptan clinical development program","volume":"13","author":"Jacob","year":"2022","journal-title":"Mol. Autism."},{"issue":"6","key":"10.1016\/j.pnpbp.2024.111176_bb0750","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1007\/s00213-013-3289-0","article-title":"The challenges of clinical trials in fragile X syndrome","volume":"231","author":"Jacquemont","year":"2014","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2024.111176_bb0755","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1093\/ajcn\/80.6.1611","article-title":"Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism","volume":"80","author":"James","year":"2004","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.pnpbp.2024.111176_bb0760","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1002\/ajmg.b.30366","article-title":"Metabolic endophenotype and related genotypes are associated with oxidative stress in children with autism","volume":"141B","author":"James","year":"2006","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.pnpbp.2024.111176_bb0765","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1096\/fj.08-128926","article-title":"Cellular and mitochondrial glutathione redox imbalance in lymphoblastoid cells derived from children with autism","volume":"23","author":"James","year":"2009","journal-title":"FASEB J."},{"key":"10.1016\/j.pnpbp.2024.111176_bb0770","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3945\/ajcn.2008.26615","article-title":"Efficacy of methylcobalamin and folinic acid treatment on glutathione redox status in children with autism","volume":"89","author":"James","year":"2009","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.pnpbp.2024.111176_bb0775","article-title":"Effects of vitamin D supplementation on core symptoms, serum serotonin, and interleukin-6 in children with autism spectrum disorders: A randomized clinical trial","volume":"79\u201380","author":"Javadfar","year":"2020","journal-title":"Nutrition"},{"key":"10.1016\/j.pnpbp.2024.111176_bb0780","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.brainres.2006.02.081","article-title":"Alzheimer\u2019s disease drugs promote neurogenesis","volume":"1085","author":"Jin","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.pnpbp.2024.111176_bb0785","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.2174\/18715206113139990319","article-title":"Omega-3 polyunsaturated fatty acids and cancer","volume":"13","author":"Jing","year":"2013","journal-title":"Anti Cancer Agents Med. Chem."},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111176_bb0790","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/acps.12644","article-title":"Use of psychotropic drugs in patients with autism spectrum disorders: a systematic review","volume":"135","author":"Jobski","year":"2017","journal-title":"Acta Psychiatr. Scand."},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111176_bb0795","first-page":"251","article-title":"Prediction of behavioral improvement through resting-State electroencephalography and clinical severity in a randomized controlled trial testing bumetanide in autism Spectrum disorder","volume":"8","author":"Juarez-Martinez","year":"2023","journal-title":"Biol. Psychiatr. Cogn. Neurosci. Neuroimag."},{"key":"10.1016\/j.pnpbp.2024.111176_bb0800","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.neuroscience.2012.02.025","article-title":"GABA(a) and GABA(B) receptors have opposite effects on synaptic glutamate release on the nucleus tractus solitarii neurons","volume":"209","author":"Kang","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.pnpbp.2024.111176_bb0805","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.psyneuen.2017.09.022","article-title":"Intranasal oxytocin, social cognition and neurodevelopmental disorders: a meta-analysis","volume":"87","author":"Keech","year":"2018","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.pnpbp.2024.111176_bb0810","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1038\/bjp.2008.356","article-title":"Luteolin inhibits myelin basic protein-induced human mast cell activation and mast cell dependent stimulation of Jurkat T cells","volume":"155","author":"Kempuraj","year":"2008","journal-title":"Br. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.pnpbp.2024.111176_bb0815","first-page":"455","article-title":"Pharmacologic Management of Agitation and Aggression in a pediatric emergency department - a retrospective cohort study","volume":"23","author":"Kendrick","year":"2018","journal-title":"J. Pediatr. Pharmacol. Ther."},{"key":"10.1016\/j.pnpbp.2024.111176_bb0820","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/128_2012_339","article-title":"Keap1-nrf2 signaling: a target for cancer prevention by sulforaphane","volume":"329","author":"Kensler","year":"2013","journal-title":"Top. Curr. Chem."},{"issue":"18","key":"10.1016\/j.pnpbp.2024.111176_bb0825","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1056\/NEJMoa1604221","article-title":"Acute neurologic disorder from an inhibitor of fatty acid amide hydrolase","volume":"375","author":"Kerbrat","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.pnpbp.2024.111176_bb0830","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1136\/archdischild-2017-312783","article-title":"Lack of effect of vitamin D3 supplementation in autism: a 20-week, placebo-controlled RCT","volume":"102","author":"Kerley","year":"2017","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.pnpbp.2024.111176_bb0835","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1080\/10937400600882079","article-title":"Evidence of toxicity, oxidative stress, and neuronal insult in autism","volume":"9","author":"Kern","year":"2006","journal-title":"J. Toxicol. Environ. Health B Crit. Rev."},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111176_bb0840","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1023\/A:1015441428154","article-title":"Efficacy of porcine secretin in children with autism and pervasive developmental disorder","volume":"32","author":"Kern","year":"2002","journal-title":"J. Autism Dev. Disord."},{"key":"10.1016\/j.pnpbp.2024.111176_bb0845","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1152\/physrev.00011.2010","article-title":"Physiology of microglia","volume":"91","author":"Kettenmann","year":"2011","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.pnpbp.2024.111176_bb0850","doi-asserted-by":"crossref","first-page":"906","DOI":"10.2174\/1871527321666220517112612","article-title":"Oxytocin effect in adult patients with autism: an updated systematic review and Meta-analysis of randomized controlled trials","volume":"22","author":"Kiani","year":"2023","journal-title":"CNS Neurol. Disord. Drug Targets"},{"issue":"5","key":"10.1016\/j.pnpbp.2024.111176_bb0855","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1089\/cap.2012.0127","article-title":"Tetrahydrobiopterin as a treatment for autism spectrum disorders: a double-blind, placebo-controlled trial","volume":"23","author":"Klaiman","year":"2013","journal-title":"J. Child Adolesc. Psychopharmacol."},{"issue":"5","key":"10.1016\/j.pnpbp.2024.111176_bb0860","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.3390\/nu13051552","article-title":"Probiotic and oxytocin combination therapy in patients with autism Spectrum disorder: a randomized, double-blinded, Placebo-controlled pilot trial","volume":"13","author":"Kong","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.pnpbp.2024.111176_bb0865","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/0014-2999(89)90384-1","article-title":"Memantine displaces [3H]MK-801 at therapeutic concentrations in postmortem human frontal cortex","volume":"166","author":"Kornhuber","year":"1989","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2024.111176_bb0870","first-page":"955","article-title":"Luteolin inhibits mast cell-mediated allergic inflammation","volume":"27","author":"Kritas","year":"2013","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"10.1016\/j.pnpbp.2024.111176_bb0875","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s00213-005-0246-6","article-title":"N-acetylcysteine augmentation in serotonin reuptake inhibitor refractory obsessive-compulsive disorder","volume":"184","author":"Lafleur","year":"2006","journal-title":"Psychoph"},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111176_bb0880","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.3390\/molecules28031344","article-title":"Cation-chloride cotransporters KCC2 and NKCC1 as therapeutic targets in neurological and neuropsychiatric disorders","volume":"28","author":"Lam","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.pnpbp.2024.111176_bb0885","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1093\/brain\/awf160","article-title":"Nicotinic receptor abnormalities in the cerebellar cortex in autism","volume":"125","author":"Lee","year":"2002","journal-title":"Brain"},{"issue":"12","key":"10.1016\/j.pnpbp.2024.111176_bb0890","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1111\/j.1651-2227.2010.01933.x","article-title":"The diuretic bumetanide decreases autistic behaviour in five infants treated during 3 months with no side effects","volume":"99","author":"Lemonnier","year":"2010","journal-title":"Acta Paediatr."},{"issue":"12","key":"10.1016\/j.pnpbp.2024.111176_bb0895","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2012.124","article-title":"A randomised controlled trial of bumetanide in the treatment of autism in children","volume":"2","author":"Lemonnier","year":"2012","journal-title":"Transl. Psychiatry"},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111176_bb0900","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2017.10","article-title":"Effects of bumetanide on neurobehavioral function in children and adolescents with autism spectrum disorders","volume":"7","author":"Lemonnier","year":"2017","journal-title":"Transl. Psychiatry"},{"issue":"2\u20133","key":"10.1016\/j.pnpbp.2024.111176_bb0905","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/BF01273191","article-title":"Inositol treatment of autism","volume":"104","author":"Levine","year":"1997","journal-title":"J. Neural Transm. (Vienna)"},{"issue":"8","key":"10.1016\/j.pnpbp.2024.111176_bb0910","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1136\/adc.88.8.731","article-title":"Children with autistic spectrum disorders. I: comparison of placebo and single dose of human synthetic secretin","volume":"88","author":"Levy","year":"2003","journal-title":"Arch. Dis. Child."},{"issue":"13\u201314","key":"10.1016\/j.pnpbp.2024.111176_bb0915","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.jchromb.2011.02.018","article-title":"Sensitive isotope dilution liquid chromatography\/tandem mass spectrometry method for quantitative analysis of bumetanide in serum and brain tissue","volume":"879","author":"Li","year":"2011","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111176_bb0920","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/s42003-024-06102-y","article-title":"Metabolic network analysis of pre-ASD newborns and 5-year-old children with autism spectrum disorder","volume":"7","author":"Lingampelly","year":"2024","journal-title":"Commun. Biol."},{"key":"10.1016\/j.pnpbp.2024.111176_bb0925","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.nbd.2010.11.010","article-title":"Genome-wide expression studies in autism spectrum disorder, Rett syndrome, and down syndrome","volume":"45","author":"Lintas","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pnpbp.2024.111176_bb0930","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/nrd1958","article-title":"Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond","volume":"5","author":"Lipton","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"issue":"4","key":"10.1016\/j.pnpbp.2024.111176_bb0935","doi-asserted-by":"crossref","first-page":"820","DOI":"10.3390\/nu11040820","article-title":"Effects of Lactobacillus plantarum PS128 on Children with Autism Spectrum Disorder in Taiwan: A Randomized, Double-Blind, Placebo-Controlled Trial","volume":"11","author":"Liu","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.pnpbp.2024.111176_bb0940","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s13105-013-0265-4","article-title":"Role of omega-3 fatty acids in obesity, metabolic syndrome, and cardiovascular diseases: a review of the evidence","volume":"69","author":"Lorente-Cebri\u00e1n","year":"2013","journal-title":"J. Physiol. Biochem."},{"key":"10.1016\/j.pnpbp.2024.111176_bb0945","doi-asserted-by":"crossref","DOI":"10.1177\/2164957X17735826","article-title":"Sulforaphane from Broccoli Reduces Symptoms of Autism: A Follow-up Case Series from a Randomized Double-blind Study","volume":"6","author":"Lynch","year":"2017","journal-title":"Glob. Adv. Health Med."},{"key":"10.1016\/j.pnpbp.2024.111176_bb0950","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.neures.2008.12.006","article-title":"NMDA receptor antagonist memantine promotes cell proliferation and production of mature granule neurons in the adult hippocampus","volume":"63","author":"Maekawa","year":"2009","journal-title":"Neurosci. Res."},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111176_bb0955","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0006-3223(00)01109-4","article-title":"Allosteric sensitization of nicotinic receptors by galantamine, a new treatment strategy for Alzheimer\u2019s disease","volume":"49","author":"Maelicke","year":"2001","journal-title":"Biol. Psychiatry"},{"issue":"12","key":"10.1016\/j.pnpbp.2024.111176_bb0960","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1007\/s00787-019-01333-5","article-title":"Baclofen as an adjuvant therapy for autism: a randomized, double-blind, placebo-controlled trial","volume":"28","author":"Mahdavinasab","year":"2019","journal-title":"Eur. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.pnpbp.2024.111176_bb0965","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13229-015-0010-7","article-title":"A randomized, placebo controlled trial of omega-3 fatty acids in the treatment of young children with autism","volume":"6","author":"Mankad","year":"2015","journal-title":"Mol. Autism"},{"key":"10.1016\/j.pnpbp.2024.111176_bb0970","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1097\/MIB.0b013e3182810122","article-title":"Polyunsaturated fatty acids in inflammatory bowel diseases: a reappraisal of effects and therapeutic approaches","volume":"19","author":"Marion-Letellier","year":"2013","journal-title":"Inflamm. Bowel Dis."},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111176_bb0975","first-page":"355","article-title":"Paradoxical reactions elicited by diazepam in children with classic autism","volume":"2","author":"Marrosu","year":"1987","journal-title":"Funct. Neurol."},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111176_bb0980","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/0014-2999(93)90037-I","article-title":"The neuroprotective agent riluzole inhibits release of glutamate and aspartate from slices of hippocampal area CA1","volume":"250","author":"Martin","year":"1993","journal-title":"Eur. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.pnpbp.2024.111176_bb0985","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/0006-3223(85)90019-8","article-title":"Vitamin B6, magnesium, and combined B6-mg: therapeutic effects in childhood autism","volume":"20","author":"Martineau","year":"1985","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111176_bb0990","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.jaac.2019.05.033","article-title":"Sensory-to-cognitive systems integration is associated with clinical severity in autism Spectrum disorder","volume":"59","author":"Mart\u00ednez","year":"2020","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.pnpbp.2024.111176_bb0995","doi-asserted-by":"crossref","first-page":"870","DOI":"10.2353\/ajpath.2010.090452","article-title":"Memantine improves cognition and reduces Alzheimer\u2019s-like neuropathology in transgenic mice","volume":"176","author":"Martinez-Coria","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.pnpbp.2024.111176_bb1000","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1172\/JCI76304","article-title":"Gut\/brain axis and the microbiota","volume":"125","author":"Mayer","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.pnpbp.2024.111176_bb1005","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jsbmb.2018.10.017","article-title":"A randomised controlled trial of vitamin D and omega-3 long chain polyunsaturated fatty acids in the treatment of irritability and hyperactivity among children with autism spectrum disorder","volume":"187","author":"Mazahery","year":"2019","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"5","key":"10.1016\/j.pnpbp.2024.111176_bb1010","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1007\/s10803-018-3860-y","article-title":"A randomised-controlled trial of vitamin D and Omega-3 long chain polyunsaturated fatty acids in the treatment of Core symptoms of autism Spectrum disorder in children","volume":"49","author":"Mazahery","year":"2019","journal-title":"J. Autism Dev. Disord."},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111176_bb1015","doi-asserted-by":"crossref","first-page":"661","DOI":"10.3390\/nu12030661","article-title":"Inflammation (IL-1\u03b2) Modifies the Effect of Vitamin D and Omega-3 Long Chain Polyunsaturated Fatty Acids on Core Symptoms of Autism Spectrum Disorder-An Exploratory Pilot Study\u2021","volume":"12","author":"Mazahery","year":"2020","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111176_bb1020","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.chom.2023.11.021","article-title":"Precision microbial intervention improves social behavior but not autism severity: A pilot double-blind randomized placebo-controlled trial","volume":"32","author":"Mazzone","year":"2024","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.pnpbp.2024.111176_bb1025","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.euroneuro.2021.05.010","article-title":"Drug development for Autism Spectrum Disorder (ASD): Progress, challenges, and future directions","volume":"48","author":"McCracken","year":"2021","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"5","key":"10.1016\/j.pnpbp.2024.111176_bb1030","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1542\/peds.2013-3995","article-title":"Gastrointestinal symptoms in autism spectrum disorder: a meta-analysis","volume":"133","author":"McElhanon","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/j.pnpbp.2024.111176_bb1035","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.anaerobe.2009.09.002","article-title":"Evidence-based review of probiotics for antibiotic-associated diarrhea and Clostridium difficile infections","volume":"15","author":"McFarland","year":"2009","journal-title":"Anaerobe"},{"issue":"7","key":"10.1016\/j.pnpbp.2024.111176_bb1045","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1002\/aur.3172","article-title":"Comparison of propofol-esketamine versus propofol-sufentanil for deep sedation and analgesia in children with autism: a randomized double-blind clinical trial","volume":"17","author":"Miao","year":"2024","journal-title":"Autism Res."},{"key":"10.1016\/j.pnpbp.2024.111176_bb1050","article-title":"Riluzole for amyotrophic lateral sclerosis (ALS)\/motor neuron disease (MND)","volume":"3","author":"Miller","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.pnpbp.2024.111176_bb1055","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1124\/jpet.104.071027","article-title":"Memantine improves spatial learning in a transgenic mouse model of Alzheimer\u2019s disease","volume":"311","author":"Minkeviciene","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pnpbp.2024.111176_bb1060","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13229-015-0062-8","article-title":"A randomized, placebo-controlled trial of D-cycloserine for the enhancement of social skills training in autism spectrum disorders","volume":"7","author":"Minshawi","year":"2016","journal-title":"Mol Autism."},{"key":"10.1016\/j.pnpbp.2024.111176_bb1065","doi-asserted-by":"crossref","first-page":"20","DOI":"10.20517\/rdodj.2023.21","article-title":"Molecular mechanisms for targeted treatments in fragile X syndrome","volume":"2","author":"Miranda","year":"2023","journal-title":"Rare Dis. Orphan. Drugs J."},{"issue":"19","key":"10.1016\/j.pnpbp.2024.111176_bb1070","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1001\/jama.2008.607","article-title":"Chelation therapy trials halted","volume":"300","author":"Mitka","year":"2008","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111176_bb1075","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1089\/cap.2017.0055","article-title":"Simvastatin as an adjunctive therapy to risperidone in treatment of autism: a randomized, double-blind, placebo-controlled clinical trial","volume":"28","author":"Moazen-Zadeh","year":"2018","journal-title":"J. Child Adolesc. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.pnpbp.2024.111176_bb1080","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/YPG.0b013e32832cebd2","article-title":"Aberrations in folate metabolic pathway and altered susceptibility to autism","volume":"19","author":"Mohammad","year":"2009","journal-title":"Psychiatr. Genet."},{"issue":"6","key":"10.1016\/j.pnpbp.2024.111176_bb1085","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1023\/A:1021202930206","article-title":"Lack of benefit of intravenous synthetic human secretin in the treatment of autism","volume":"32","author":"Molloy","year":"2002","journal-title":"J. Autism Dev. Disord."},{"issue":"7","key":"10.1016\/j.pnpbp.2024.111176_bb1090","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/pcn.13016","article-title":"Sulforaphane as an adjunctive treatment for irritability in children with autism spectrum disorder: a randomized, double-blind, placebo-controlled clinical trial","volume":"74","author":"Momtazmanesh","year":"2020","journal-title":"Psychiatry Clin. Neurosci."},{"issue":"4","key":"10.1016\/j.pnpbp.2024.111176_bb1095","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.biopsych.2010.05.024","article-title":"Microglial activation and increased microglial density observed in the dorsolateral prefrontal cortex in autism","volume":"68","author":"Morgan","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2024.111176_bb1100","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.psychres.2018.03.061","article-title":"Coenzyme Q10 supplementation reduces oxidative stress and decreases antioxidant enzyme activity in children with autism spectrum disorders","volume":"265","author":"Mousavinejad","year":"2018","journal-title":"Psychiatry Res."},{"issue":"4","key":"10.1016\/j.pnpbp.2024.111176_bb1105","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0162-20.2020","article-title":"A Differential Effect of Lovastatin versus Simvastatin in Neurodevelopmental Disorders","volume":"7","author":"Muscas","year":"2020","journal-title":"eNeuro"},{"key":"10.1016\/j.pnpbp.2024.111176_bb1110","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.neuroscience.2010.01.033","article-title":"Pigment epithelium-derived factor up-regulation induced by memantine, an N-methyl-Daspartate receptor antagonist, is involved in increased proliferation of hippocampal progenitor cells","volume":"167","author":"Namba","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.pnpbp.2024.111176_bb1115","series-title":"Prescribing Information. Dublin, Ireland: Forest Pharmaceuticals","author":"Namenda","year":"2010"},{"issue":"Pt 4","key":"10.1016\/j.pnpbp.2024.111176_bb1120","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1093\/brain\/awr041","article-title":"Neuronal chloride accumulation and excitatory GABA underlie aggravation of neonatal epileptiform activities by phenobarbital","volume":"134","author":"Nardou","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.pnpbp.2024.111176_bb1125","article-title":"l-carnitine adjunct to risperidone for treatment of autism spectrum disorder-associated behaviors: a randomized, double-blind clinical trial","author":"Nasiri","year":"2023","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2024.111176_bb1130","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.mito.2013.08.006","article-title":"Metabolic features of the cell danger response","volume":"16","author":"Naviaux","year":"2014","journal-title":"Mitochondrion"},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111176_bb1135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0057380","article-title":"Antipurinergic therapy corrects the autism-like features in the poly(IC) mouse model","volume":"8","author":"Naviaux","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.pnpbp.2024.111176_bb1140","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2014.33","article-title":"Reversal of autism-like behaviors and metabolism in adult mice with single-dose antipurinergic therapy","volume":"4","author":"Naviaux","year":"2014","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.pnpbp.2024.111176_bb1145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2040-2392-6-1","article-title":"Antipurinergic therapy corrects the autism-like features in the fragile X (Fmr1 knockout) mouse model","volume":"6","author":"Naviaux","year":"2015","journal-title":"Mol. Autism."},{"issue":"7","key":"10.1016\/j.pnpbp.2024.111176_bb1150","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/acn3.424","article-title":"Low-dose suramin in autism spectrum disorder: a small, phase I\/II, randomized clinical trial","volume":"4","author":"Naviaux","year":"2017","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111176_bb1155","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/WNF.0000000000000063","article-title":"N-acetylcysteine as an adjunctive therapy to risperidone for treatment of irritability in autism: a randomized, double-blind, placebo-controlled clinical trial of efficacy and safety","volume":"38","author":"Nikoo","year":"2015","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.pnpbp.2024.111176_bb1160","doi-asserted-by":"crossref","first-page":"110695","DOI":"10.1016\/j.pnpbp.2022.110695","article-title":"Melatonin for sleep disorders in people with autism: systematic review and meta-analysis","volume":"123","author":"Nogueira","year":"2022","journal-title":"Progr. NeuroPsychopharmacol. Biol. Psychiatr."},{"issue":"5","key":"10.1016\/j.pnpbp.2024.111176_bb1165","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1111\/j.1471-4159.2007.04889.x","article-title":"Minocycline decreases in vitromicroglial motility, beta1-integrin, and Kv1.3 channel expression","volume":"103","author":"Nutile-McMenemy","year":"2007","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111176_bb1170","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/BF01061422","article-title":"Pharmacokinetics and bioavailability of reduced and oxidized N-acetylcysteine","volume":"34","author":"Olsson","year":"1988","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"2","key":"10.1016\/j.pnpbp.2024.111176_bb1175","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1007\/s10803-022-05784-9","article-title":"Efficacy of Sulforaphane in treatment of children with autism Spectrum disorder: a randomized double-blind placebo-controlled multi-center trial","volume":"54","author":"Ou","year":"2024","journal-title":"J. Autism Dev. Disord."},{"issue":"2","key":"10.1016\/j.pnpbp.2024.111176_bb1180","doi-asserted-by":"crossref","first-page":"e200","DOI":"10.1212\/WNL.0000000000007749","article-title":"A randomized controlled trial with everolimus for IQ and autism in tuberous sclerosis complex","volume":"93","author":"Overwater","year":"2019","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.pnpbp.2024.111176_bb1185","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1097\/00004583-200111000-00009","article-title":"Multisite, double-blind, placebo-controlled trial of porcine secretin in autism","volume":"40","author":"Owley","year":"2001","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"issue":"19","key":"10.1016\/j.pnpbp.2024.111176_bb1190","doi-asserted-by":"crossref","first-page":"10609","DOI":"10.1073\/pnas.1919050117","article-title":"Neonatal CSF vasopressin concentration predicts later medical record diagnoses of autism spectrum disorder","volume":"117","author":"Oztan","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"10","key":"10.1016\/j.pnpbp.2024.111176_bb1195","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s00011-014-0760-2","article-title":"Docosahexanoic acid antagonizes TNF-\u03b1-induced necroptosis by attenuating oxidative stress, ceramide production, lysosomal dysfunction, and autophagic features","volume":"63","author":"Pacheco","year":"2014","journal-title":"Inflamm. Res."},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111176_bb1200","doi-asserted-by":"crossref","first-page":"6084","DOI":"10.1038\/s41467-021-26131-z","article-title":"mTOR-related synaptic pathology causes autism spectrum disorder-associated functional hyperconnectivity","volume":"12","author":"Pagani","year":"2021","journal-title":"Nat. Commun."},{"issue":"71","key":"10.1016\/j.pnpbp.2024.111176_bb1205","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"Brit. Med. J."},{"key":"10.1016\/j.pnpbp.2024.111176_bb1210","article-title":"A double-blind randomised controlled trial of prebiotic supplementation in children with autism: effects on parental quality of life, child behaviour, gastrointestinal symptoms, and the microbiome","author":"Palmer","year":"2024","journal-title":"J. Autism Dev. Disord."},{"issue":"6\u20137","key":"10.1016\/j.pnpbp.2024.111176_bb1215","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.bbabio.2010.04.018","article-title":"Mitochondrial dysfunction in autism spectrum disorders: cause or effect?","volume":"1797","author":"Palmieri","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"issue":"12","key":"10.1016\/j.pnpbp.2024.111176_bb1220","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.euroneuro.2017.08.426","article-title":"Randomized trial of omega-3 for autism spectrum disorders: effect on cell membrane composition and behavior","volume":"27","author":"Parellada","year":"2017","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.pnpbp.2024.111176_bb1225","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.701729","volume":"12","author":"Parellada","year":"2021","journal-title":"Front. Psychiatr."},{"issue":"491","key":"10.1016\/j.pnpbp.2024.111176_bb1230","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aau7356","article-title":"A randomized placebo-controlled pilot trial shows that intranasal vasopressin improves social deficits in children with autism","volume":"11","author":"Parker","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.pnpbp.2024.111176_bb1235","doi-asserted-by":"crossref","first-page":"173607","DOI":"10.1016\/j.pbb.2023.173607","article-title":"A systematic review of cannabidiol trials in neurodevelopmental disorders","volume":"230","author":"Parrella","year":"2023","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"4","key":"10.1016\/j.pnpbp.2024.111176_bb1240","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3390\/brainsci10040233","article-title":"P-cresol alters brain dopamine metabolism and exacerbates autism-like behaviors in the BTBR mouse","volume":"10","author":"Pascucci","year":"2020","journal-title":"Brain Sci."},{"issue":"11","key":"10.1016\/j.pnpbp.2024.111176_bb1245","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.44136","article-title":"Pancreatic replacement therapy for maladaptive behaviors in preschool children with autism Spectrum disorder","volume":"6","author":"Pearson","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.pnpbp.2024.111176_bb1250","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1176\/appi.ajp.158.7.1058","article-title":"Cholinergic activity in autism: abnormalities in the cerebral cortex and basal forebrain","volume":"158","author":"Perry","year":"2001","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2024.111176_bb1255","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ntt.2012.09.002","article-title":"Urinary p-cresol in autism spectrum disorder","volume":"36","author":"Persico","year":"2013","journal-title":"Neurotoxicol. Teratol."},{"issue":"10","key":"10.1016\/j.pnpbp.2024.111176_bb1260","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/j.euroneuro.2015.06.009","article-title":"Unmet needs in paediatric psychopharmacology: present scenario and future perspectives","volume":"25","author":"Persico","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.pnpbp.2024.111176_bb1265","doi-asserted-by":"crossref","first-page":"110326","DOI":"10.1016\/j.pnpbp.2021.110326","article-title":"The pediatric psychopharmacology of autism spectrum disorder: a systematic review - part I: the past and the present","volume":"110","author":"Persico","year":"2021","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111176_bb1270","doi-asserted-by":"crossref","first-page":"13","DOI":"10.20517\/rdodj.2023.08","article-title":"Coenzyme Q10, Vitamin E and Polyvitamin B: an exploratory double-blind randomized cross-over study in Phelan-McDermid Syndrome","volume":"2","author":"Persico","year":"2023","journal-title":"Rare Disease and Orphan Drugs J."},{"key":"10.1016\/j.pnpbp.2024.111176_bb1275","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1212\/WNL.56.6.709","article-title":"Homocarnosine and seizure control in juvenile myoclonic epilepsy and complex partial seizures","volume":"56","author":"Petroff","year":"2001","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.pnpbp.2024.111176_bb1280","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.sleep.2009.11.014","article-title":"Advances in pediatric restless legs syndrome: Iron, genetics, diagnosis and treatment","volume":"11","author":"Picchietti","year":"2010","journal-title":"Sleep Med."},{"key":"10.1016\/j.pnpbp.2024.111176_bb1285","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.bbi.2013.12.020","article-title":"Anti-brain antibodies are associated with more severe cognitive and behavioral profiles in Italian children with autism Spectrum disorder","volume":"38","author":"Piras","year":"2014","journal-title":"Brain Behav. Immun."},{"issue":"11","key":"10.1016\/j.pnpbp.2024.111176_bb1290","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1176\/appi.ajp.161.11.2115","article-title":"A pilot study of D-cycloserine in subjects with autistic disorder","volume":"161","author":"Posey","year":"2004","journal-title":"Am. J. Psychiatry"},{"issue":"11","key":"10.1016\/j.pnpbp.2024.111176_bb1295","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1007\/s00210-021-02161-8","article-title":"Coenzyme Q10 a mitochondrial restorer for various brain disorders","volume":"394","author":"Pradhan","year":"2021","journal-title":"Naunyn Schmiedeberg\u2019s Arch. Pharmacol."},{"issue":"8","key":"10.1016\/j.pnpbp.2024.111176_bb1300","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1038\/s41386-019-0333-8","article-title":"Effects of cannabidiol on brain excitation and inhibition systems; a randomised placebo-controlled single dose trial during magnetic resonance spectroscopy in adults with and without autism spectrum disorder","volume":"44","author":"Pretzsch","year":"2019","journal-title":"Neuropsychopharmacology"},{"issue":"5","key":"10.1016\/j.pnpbp.2024.111176_bb1305","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/aur.1300","article-title":"Association between MTHFR gene polymorphisms and the risk of autism spectrum disorders: a meta-analysis","volume":"6","author":"Pu","year":"2013","journal-title":"Autism Res."},{"issue":"19","key":"10.1016\/j.pnpbp.2024.111176_bb1310","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1056\/NEJMoa043160","article-title":"Autoantibodies to folate receptors in the cerebral folate deficiency syndrome","volume":"352","author":"Ramaekers","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111176_bb1315","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/mp.2012.22","article-title":"Role of folate receptor autoantibodies in infantile autism","volume":"18","author":"Ramaekers","year":"2013","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2024.111176_bb1320","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.biochi.2016.04.005","article-title":"The basis for folinic acid treatment in neuro-psychiatric disorders","volume":"126","author":"Ramaekers","year":"2016","journal-title":"Biochimie"},{"issue":"5","key":"10.1016\/j.pnpbp.2024.111176_bb1325","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.immuni.2009.09.010","article-title":"Chemokines and chemokine receptors: standing at the crossroads of immunobiology and neurobiology","volume":"31","author":"Ransohoff","year":"2009","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111176_bb1330","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1177\/1362361305053257","article-title":"Randomized controlled trial of transdermal secretin on behavior of children with autism","volume":"9","author":"Ratliff-Schaub","year":"2005","journal-title":"Autism"},{"key":"10.1016\/j.pnpbp.2024.111176_bb1335","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.biochi.2020.04.019","article-title":"Folinic acid improves the score of autism in the EFFET placebo-controlled randomized trial","volume":"173","author":"Renard","year":"2020","journal-title":"Biochimie"},{"issue":"Suppl. 2","key":"10.1016\/j.pnpbp.2024.111176_bb1340","doi-asserted-by":"crossref","first-page":"S154","DOI":"10.1542\/peds.2012-0900M","article-title":"Iron status in children with autism spectrum disorder","volume":"130 Suppl 2","author":"Reynolds","year":"2012","journal-title":"Pediatrics"},{"key":"10.1016\/j.pnpbp.2024.111176_bb1345","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.pediatrneurol.2019.07.015","article-title":"Randomized, placebo-controlled trial of ferrous sulfate to treat insomnia in children with autism Spectrum disorders","volume":"104","author":"Reynolds","year":"2020","journal-title":"Pediatr. Neurol."},{"issue":"5","key":"10.1016\/j.pnpbp.2024.111176_bb1350","doi-asserted-by":"crossref","DOI":"10.1542\/peds.107.5.e71","article-title":"Repeated doses of porcine secretin in the treatment of autism: a randomized, placebo-controlled trial","volume":"107","author":"Roberts","year":"2001","journal-title":"Pediatrics"},{"key":"10.1016\/j.pnpbp.2024.111176_bb1355","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.neuropharm.2017.02.006","article-title":"Multiple blood-brain barrier transport mechanisms limit bumetanide accumulation, and therapeutic potential, in the mammalian brain","volume":"117","author":"R\u00f6mermann","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2024.111176_bb1360","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2012.61","article-title":"Evidenceof oxidative damage and inflammation associated with low glutathione redox status in the autism brain","volume":"2","author":"Rose","year":"2012","journal-title":"Transl. Psychiatry"},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111176_bb1365","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/mp.2010.136","article-title":"Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis","volume":"17","author":"Rossignol","year":"2012","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2024.111176_bb1370","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3389\/fped.2014.00087","article-title":"The use of medications approved for Alzheimer\u2019s disease in autism spectrum disorder: a systematic review","volume":"2","author":"Rossignol","year":"2014","journal-title":"Front. Pediatr."},{"issue":"11","key":"10.1016\/j.pnpbp.2024.111176_bb1375","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.3390\/jpm11111141","article-title":"Cerebral Folate Deficiency, Folate Receptor Alpha Autoantibodies and Leucovorin (Folinic Acid) Treatment in Autism Spectrum Disorders: A Systematic Review and Meta-Analysis","volume":"11","author":"Rossignol","year":"2021","journal-title":"J. Pers Med."},{"issue":"5","key":"10.1016\/j.pnpbp.2024.111176_bb1380","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1034\/j.1601-183X.2003.00037.x","article-title":"Model of autism: increased ratio of excitation\/inhibition in key neural systems","volume":"2","author":"Rubenstein","year":"2003","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.pnpbp.2024.111176_bb1385","doi-asserted-by":"crossref","first-page":"104723","DOI":"10.1016\/j.neubiorev.2022.104723","article-title":"Efficacy on sleep parameters and tolerability of melatonin in individuals with sleep or mental disorders: a systematic review and meta-analysis","volume":"139","author":"Salanitro","year":"2022","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"2","key":"10.1016\/j.pnpbp.2024.111176_bb1390","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jaac.2022.03.033","article-title":"Systematic review and Meta-analysis: efficacy of pharmacological interventions for irritability and emotional dysregulation in autism Spectrum disorder and predictors of response","volume":"62","author":"Salazar de Pablo","year":"2023","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.pnpbp.2024.111176_bb1395","series-title":"New Protective Roles of Selected Nutrients in Human Nutrition","first-page":"109","article-title":"Omega-3 fatty acids: molecular and biochemical aspects","author":"Salem","year":"1989"},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111176_bb1400","doi-asserted-by":"crossref","first-page":"596","DOI":"10.3390\/metabo2030596","article-title":"Metabolic and pharmacokinetic differentiation of STX209 and racemic baclofen in humans","volume":"2","author":"Sanchez-Ponce","year":"2012","journal-title":"Metabolites"},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111176_bb1405","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0210064","article-title":"Pilot study of probiotic\/colostrum supplementation on gut function in children with autism and gastrointestinal symptoms","volume":"14","author":"Sanctuary","year":"2019","journal-title":"PLoS One"},{"issue":"24","key":"10.1016\/j.pnpbp.2024.111176_bb1410","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1056\/NEJM199912093412404","article-title":"Lack of benefit of a single dose of synthetic human secretin in the treatment of autism and pervasive developmental disorder","volume":"341","author":"Sandler","year":"1999","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.pnpbp.2024.111176_bb1415","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/bcp.13496","article-title":"Nutraceuticals: opening the debate for a regulatory framework","volume":"84","author":"Santini","year":"2018","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.pnpbp.2024.111176_bb1420","doi-asserted-by":"crossref","first-page":"550593","DOI":"10.3389\/fpsyt.2020.550593","article-title":"Effects of Probiotic Supplementation on Gastrointestinal, Sensory and Core Symptoms in Autism Spectrum Disorders: A Randomized Controlled Trial","volume":"11","author":"Santocchi","year":"2020","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.pnpbp.2024.111176_bb1425","doi-asserted-by":"crossref","first-page":"6023","DOI":"10.1242\/dev.01532","article-title":"Alpha3beta1 integrin modulates neuronal migration and placement during early stages of cerebral cortical development","volume":"131","author":"Schmid","year":"2004","journal-title":"Development"},{"key":"10.1016\/j.pnpbp.2024.111176_bb1430","doi-asserted-by":"crossref","first-page":"5192","DOI":"10.1038\/s41598-023-30909-0","article-title":"Results of a phase Ib study of SB-121, an investigational probiotic formulation, a randomized controlled trial in participants with autism spectrum disorder","volume":"13","author":"Schmitt","year":"2023","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.pnpbp.2024.111176_bb1435","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.3390\/biomedicines10071685","article-title":"A Placebo-Controlled Trial of Cannabinoid Treatment for Disruptive Behavior in Children and Adolescents with Autism Spectrum Disorder: Effects on Sleep Parameters as Measured by the CSHQ","volume":"10","author":"Schnapp","year":"2022","journal-title":"Biomedicines"},{"issue":"4","key":"10.1016\/j.pnpbp.2024.111176_bb1440","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1021\/acs.jmedchem.9b01478","article-title":"Discovery of Balovaptan, a vasopressin 1a receptor antagonist for the treatment of autism Spectrum disorder","volume":"63","author":"Schnider","year":"2020","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.pnpbp.2024.111176_bb1445","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.neuron.2018.11.018","article-title":"Mechanisms Underlying Microbial-Mediated Changes in Social Behavior in Mouse Models of Autism Spectrum Disorder","volume":"101","author":"Sgritta","year":"2019","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.pnpbp.2024.111176_bb1450","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/WNF.0000000000000544","article-title":"Effect of adding l -carnitine to risperidone on behavioral, cognitive, social, and physical symptoms in children and adolescents with autism: a randomized double-blinded placebo-controlled clinical trial","volume":"46","author":"Shakibaei","year":"2023","journal-title":"Clin. Neuropharmacol."},{"issue":"5","key":"10.1016\/j.pnpbp.2024.111176_bb1455","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1177\/0269881116636107","article-title":"BAP position statement: off-label prescribing of psychotropic medication to children and adolescents","volume":"30","author":"Sharma","year":"2016","journal-title":"J. Psychopharmacol."},{"issue":"6","key":"10.1016\/j.pnpbp.2024.111176_bb1460","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1016\/j.cell.2019.05.004","article-title":"Human Gut Microbiota from Autism Spectrum Disorder Promote Behavioral Symptoms in Mice","volume":"177","author":"Sharon","year":"2019","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111176_bb1465","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1186\/s12888-022-04151-3","article-title":"Carbon monoxide (CO) correlates with symptom severity, autoimmunity, and responses to probiotics treatment in a cohort of children with autism spectrum disorder (ASD): a post-hoc analysis of a randomized controlled trial","volume":"22","author":"Sherman","year":"2022","journal-title":"BMC Psychiatr."},{"issue":"10","key":"10.1016\/j.pnpbp.2024.111176_bb1470","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025340","article-title":"Alteration of plasma glutamate and glutamine levels in children with high-functioning autism","volume":"6","author":"Shimmura","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.pnpbp.2024.111176_bb1475","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/sj.jhh.1001416","article-title":"Mecamyl- amine (Inversine): an old antihypertensive with new research di- rections","volume":"16","author":"Shytle","year":"2002","journal-title":"J. Hum. Hypertens."},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111176_bb1480","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13229-022-00488-4","article-title":"Pharmacological and dietary-supplement treatments for autism spectrum disorder: a systematic review and network meta-analysis","volume":"13","author":"Siafis","year":"2022","journal-title":"Mol. Autism."},{"key":"10.1016\/j.pnpbp.2024.111176_bb1485","doi-asserted-by":"crossref","first-page":"124548","DOI":"10.1155\/2012\/124548","article-title":"Matrix metalloproteinases and minocycline: therapeutic avenues for fragile X syndrome","volume":"2012","author":"Siller","year":"2012","journal-title":"Neural. Plast."},{"key":"10.1016\/j.pnpbp.2024.111176_bb1490","article-title":"Evaluation of the efficacy and safety of cannabidiol-rich cannabis extract in children with autism spectrum disorder: randomized, double-blind and controlled placebo clinical trial","volume":"44","author":"Silva","year":"2022","journal-title":"Trends Psychiatry Psychother."},{"key":"10.1016\/j.pnpbp.2024.111176_bb1495","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1097\/00004583-200109000-00020","article-title":"Multicenter, double-blind, placebo-controlled study of mecamylamine monotherapy for Tourette\u2019s disorder","volume":"40","author":"Silver","year":"2001","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"issue":"9","key":"10.1016\/j.pnpbp.2024.111176_bb1500","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1038\/npp.2015.66","article-title":"GABAB receptor agonist R-baclofen reverses social deficits and reduces repetitive behavior in two mouse models of autism","volume":"40","author":"Silverman","year":"2015","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111176_bb1505","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0380-16.2017","article-title":"GABA-B Agonist Baclofen Normalizes Auditory-Evoked Neural Oscillations and Behavioral Deficits in the <i>Fmr1<\/i> Knockout Mouse Model of Fragile X Syndrome","volume":"4","author":"Sinclair","year":"2017","journal-title":"eNeuro"},{"issue":"43","key":"10.1016\/j.pnpbp.2024.111176_bb1510","doi-asserted-by":"crossref","first-page":"15550","DOI":"10.1073\/pnas.1416940111","article-title":"Sulforaphane treatment of autism spectrum disorder (ASD)","volume":"111","author":"Singh","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.pnpbp.2024.111176_bb1515","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0009-8981(03)00119-0","article-title":"Changes in nitric oxide levels and antioxidant enzyme activities may have a role in the pathophysiological mechanisms involved in autism","volume":"331","author":"Sogut","year":"2003","journal-title":"Clin. Chim. Acta; Int. J. Clin. Chem."},{"issue":"9","key":"10.1016\/j.pnpbp.2024.111176_bb1520","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/s41380-019-0426-0","article-title":"Excitation-inhibition balance as a framework for investigating mechanisms in neuropsychiatric disorders","volume":"24","author":"Sohal","year":"2019","journal-title":"Mol. Psychiatry"},{"issue":"7","key":"10.1016\/j.pnpbp.2024.111176_bb1525","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1089\/cap.2021.0010","article-title":"Neurocognitive outcomes from Memantine: a pilot, double-blind, placebo-controlled trial in children with autism Spectrum disorder","volume":"31","author":"Soorya","year":"2021","journal-title":"J. Child Adolesc. Psychopharmacol."},{"issue":"5","key":"10.1016\/j.pnpbp.2024.111176_bb1530","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1651-2227.2002.tb03274.x","article-title":"Multiple doses of secretin in the treatment of autism: a controlled study","volume":"91","author":"Sponheim","year":"2002","journal-title":"Acta Paediatr."},{"issue":"7","key":"10.1016\/j.pnpbp.2024.111176_bb1535","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.jaac.2020.07.888","article-title":"Bumetanide for Core symptoms of autism Spectrum disorder (BAMBI): a single center, double-blinded, participant-randomized, placebo-controlled, Phase-2 superiority trial","volume":"60","author":"Sprengers","year":"2021","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"issue":"18","key":"10.1016\/j.pnpbp.2024.111176_bb1540","doi-asserted-by":"crossref","first-page":"7595","DOI":"10.1073\/pnas.0811343106","article-title":"Netrin-1-alpha3beta1 integrin interactions regulate the migration of interneurons through the cortical marginal zone","volume":"106","author":"Stanco","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.pnpbp.2024.111176_bb1545","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13229-018-0190-z","article-title":"Randomised controlled trial of simvastatin treatment for autism in young children with neurofibromatosis type 1 (SANTA)","volume":"9","author":"Stivaros","year":"2018","journal-title":"Mol. Autism."},{"issue":"4","key":"10.1016\/j.pnpbp.2024.111176_bb1550","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.biopsych.2003.09.001","article-title":"High nitric oxide production in autistic disorder: a possible role for interferon-gamma","volume":"55","author":"Sweeten","year":"2004","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2024.111176_bb1555","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1742-2094-10-46","article-title":"Focal brain inflammation and autism","volume":"10","author":"Theoharides","year":"2013","journal-title":"J. Neuroinflammation"},{"issue":"14","key":"10.1016\/j.pnpbp.2024.111176_bb1560","doi-asserted-by":"crossref","first-page":"9186","DOI":"10.1093\/cercor\/bhad195","article-title":"Different levels of visuospatial abilities linked to differential brain correlates underlying visual mental segmentation processes in autism","volume":"33","author":"Th\u00e9rien","year":"2023","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.pnpbp.2024.111176_bb1565","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0079-6123(02)39016-2","article-title":"Molecular pharmacology and modeling of vasopressin receptors","volume":"139","author":"Thibonnier","year":"2002","journal-title":"Prog. Brain Res."},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111176_bb1570","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0306-4530(02)00133-6","article-title":"The effects of vasopressin on human facial responses related to social communication","volume":"29","author":"Thompson","year":"2004","journal-title":"Psychoneuroendocrinology"},{"issue":"9","key":"10.1016\/j.pnpbp.2024.111176_bb1575","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0166-2236(89)90042-8","article-title":"Glycine modulation of the NMDA receptor\/channel complex","volume":"12","author":"Thomson","year":"1989","journal-title":"Trends Neurosci."},{"issue":"9","key":"10.1016\/j.pnpbp.2024.111176_bb1580","doi-asserted-by":"crossref","first-page":"797","DOI":"10.3390\/metabo12090797","article-title":"Urinary untargeted metabolic profile differentiates children with autism from their unaffected siblings","volume":"12","author":"Timperio","year":"2022","journal-title":"Metabolites"},{"key":"10.1016\/j.pnpbp.2024.111176_bib1764","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3389\/fnana.2015.00045","article-title":"From the Cajal alumni Ach\u00facarro and R\u00edo-Hortega to the rediscovery of never-resting microglia","volume":"9","author":"Tremblay","year":"2015","journal-title":"Frontiers in neuroanatomy"},{"key":"10.1016\/j.pnpbp.2024.111176_bb1590","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1159\/000059785","article-title":"Essential fatty acids in somatic growth and brain development","volume":"89","author":"Uauy","year":"2001","journal-title":"World Rev. Nutr. Diet."},{"issue":"11","key":"10.1016\/j.pnpbp.2024.111176_bb1595","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1097\/00004583-200211000-00012","article-title":"A randomized, double-blind, placebo-controlled trial of porcine versus synthetic secretin for reducing symptoms of autism","volume":"41","author":"Unis","year":"2002","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111176_bb1600","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/WNF.0000000000000033","article-title":"A trial of D-cycloserine to treat stereotypies in older adolescents and young adults with autism spectrum disorder","volume":"37","author":"Urbano","year":"2014","journal-title":"Clin. Neuropharmacol."},{"issue":"2","key":"10.1016\/j.pnpbp.2024.111176_bb1605","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1176\/appi.neuropsych.13070155","article-title":"A trial of d-cycloserine to treat the social deficit in older adolescents and young adults with autism spectrum disorders","volume":"27","author":"Urbano","year":"2015","journal-title":"J. Neuropsychiatr. Clin. Neurosci."},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111176_bb1610","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.conb.2009.12.003","article-title":"Neuronal migration mechanisms in development and disease","volume":"20","author":"Valiente","year":"2010","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.pnpbp.2024.111176_bb1615","doi-asserted-by":"crossref","first-page":"780281","DOI":"10.3389\/fpsyt.2022.780281","article-title":"Bumetanide for Irritability in Children With Sensory Processing Problems Across Neurodevelopmental Disorders: A Pilot Randomized Controlled Trial","volume":"13","author":"van Andel","year":"2022","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.pnpbp.2024.111176_bb1620","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1007\/s10803-022-05841-3","article-title":"Effects of bumetanide on neurocognitive functioning in children with autism Spectrum disorder: secondary analysis of a randomized placebo-controlled trial","volume":"54","author":"van Andel","year":"2024","journal-title":"J. Autism Dev. Disord."},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111176_bb1625","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s11910-010-0104-8","article-title":"Synapse pathology in psychiatric and neurologic disease","volume":"10","author":"van Spronsen","year":"2010","journal-title":"Curr. Neurol. Neurosci. Rep."},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111176_bb1630","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/ana.20315","article-title":"Neuroglial activation and neuroinflammation in the brain of patients with autism [published correction appears in Ann Neurol. 2005 Feb;57(2):304]","volume":"57","author":"Vargas","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.pnpbp.2024.111176_bb1635","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3389\/fncel.2018.00503","article-title":"Comparison of Three Clinical Trial Treatments for Autism Spectrum Disorder Through Multivariate Analysis of Changes in Metabolic Profiles and Adaptive Behavior","volume":"12","author":"Vargason","year":"2018","journal-title":"Front. Cell. Neurosci."},{"issue":"7","key":"10.1016\/j.pnpbp.2024.111176_bb1640","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/npp.2016.237","article-title":"Arbaclofen in children and adolescents with autism Spectrum disorder: a randomized, controlled, phase 2 trial","volume":"42","author":"Veenstra-VanderWeele","year":"2017","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"10.1016\/j.pnpbp.2024.111176_bb1645","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/MPG.0000000000000260","article-title":"Dietary docosahexaenoic acid supplementation in children with autism","volume":"58","author":"Voigt","year":"2014","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"issue":"10","key":"10.1016\/j.pnpbp.2024.111176_bb1650","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.3390\/nu12103196","article-title":"Effect of vitamin D status during pregnancy on infant neurodevelopment: the ECLIPSES study","volume":"12","author":"Voltas","year":"2020","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111176_bb1655","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1007\/s00429-016-1292-z","article-title":"NKCC1 up-regulation contributes to early post-traumatic seizures and increased post-traumatic seizure susceptibility","volume":"222","author":"Wang","year":"2017","journal-title":"Brain Struct. Funct."},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111176_bb1660","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3390\/nu13010086","article-title":"The association between vitamin D status and autism Spectrum disorder (ASD): a systematic review and Meta-analysis","volume":"13","author":"Wang","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.pnpbp.2024.111176_bb1665","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/87565648809540405","article-title":"Assessing frontal lobe functioning in children: views from developmental psychology","volume":"4","author":"Welsh","year":"1988","journal-title":"Dev. Neuropsychol."},{"key":"10.1016\/j.pnpbp.2024.111176_bb1670","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13229-016-0088-6","article-title":"A randomized placebo-controlled pilot study of N-acetylcysteine in youth with autism spectrum disorder","volume":"7","author":"Wink","year":"2016","journal-title":"Mol. Autism."},{"key":"10.1016\/j.pnpbp.2024.111176_bb1675","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13229-017-0116-1","article-title":"d-Cycloserine enhances durability of social skills training in autism spectrum disorder","volume":"8","author":"Wink","year":"2017","journal-title":"Mol Autism."},{"issue":"9","key":"10.1016\/j.pnpbp.2024.111176_bb1680","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1007\/s10803-018-3562-5","article-title":"A randomized placebo-controlled cross-over pilot study of Riluzole for drug-refractory irritability in autism Spectrum disorder","volume":"48","author":"Wink","year":"2018","journal-title":"J. Autism Dev. Disord."},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111176_bb1685","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1177\/1362361307070989","article-title":"A placebo double-blind pilot study of dextromethorphan for problematic behaviors in children with autism","volume":"11","author":"Woodard","year":"2007","journal-title":"Autism"},{"key":"10.1016\/j.pnpbp.2024.111176_bb1690","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1023\/A:1018829920158","article-title":"Blood-brain barrier transport of reduced folic acid","volume":"16","author":"Wu","year":"1999","journal-title":"Pharm. Res."},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111176_bb1695","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1055\/s-0043-1761437","article-title":"Efficacy of melatonin for insomnia in children with autism Spectrum disorder: a Meta-analysis","volume":"54","author":"Xiong","year":"2023","journal-title":"Neuropediatrics"},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111176_bb1700","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1113\/jphysiol.2004.062471","article-title":"Cl- uptake promoting depolarizing GABA actions in immature rat neocortical neurones is mediated by NKCC1","volume":"557","author":"Yamada","year":"2004","journal-title":"J. Physiol."},{"key":"10.1016\/j.pnpbp.2024.111176_bb1705","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.2147\/NDT.S407731","article-title":"The synaptic and circuit functions of vitamin D in neurodevelopment disorders","volume":"19","author":"Ye","year":"2023","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"7363","key":"10.1016\/j.pnpbp.2024.111176_bb1710","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/nature10360","article-title":"Neocortical excitation\/inhibition balance in information processing and social dysfunction","volume":"477","author":"Yizhar","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.pnpbp.2024.111176_bb1715","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1046\/j.1471-4159.1997.68031261.x","article-title":"Synaptic vesicle ultrastructural changes in the rat hippocampus induced by a combination of alpha-linolenate deficiency and a learning task","volume":"68","author":"Yoshida","year":"1997","journal-title":"J. Neurochem."},{"issue":"2","key":"10.1016\/j.pnpbp.2024.111176_bb1720","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/JCP.0b013e3182485791","article-title":"Effects of large doses of arachidonic acid added to docosahexaenoic acid on social impairment in individuals with autism spectrum disorders: a double-blind, placebo-controlled, randomized trial","volume":"32","author":"Yui","year":"2012","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2024.111176_bb1725","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/jnr.22546","article-title":"Fragile X mice: reduced long-term potentiation and N-methyl-D-aspartate receptor-mediated neurotransmission in dentate gyrus","volume":"89","author":"Yun","year":"2011","journal-title":"J. Neurosci. Res."},{"issue":"6","key":"10.1016\/j.pnpbp.2024.111176_bb1730","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.991","article-title":"Paradoxical effect of baclofen on social behavior in the fragile X syndrome mouse model","volume":"8","author":"Zeidler","year":"2018","journal-title":"Brain Behav."},{"key":"10.1016\/j.pnpbp.2024.111176_bb1735","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1146\/annurev-nutr-071811-150726","article-title":"Resolvins: anti-inflammatory and proresolving mediators derived from omega-3 polyunsaturated fatty acids","volume":"32","author":"Zhang","year":"2012","journal-title":"Annu. Rev. Nutr."},{"issue":"8","key":"10.1016\/j.pnpbp.2024.111176_bb1740","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1073\/pnas.91.8.3147","article-title":"Anticarcinogenic activities of sulforaphane and structurally related synthetic norbornyl isothiocyanates","volume":"91","author":"Zhang","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111176_bb1745","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s41398-020-0747-4","article-title":"Correction: Symptom improvement in children with autism spectrum disorder following bumetanide administration is associated with decreased GABA\/glutamate ratios","volume":"10","author":"Zhang","year":"2020","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.pnpbp.2024.111176_bb1750","doi-asserted-by":"crossref","first-page":"105412","DOI":"10.1016\/j.psyneuen.2021.105412","article-title":"Intranasal vasopressin like oxytocin increases social attention by influencing top-down control, but additionally enhances bottom-up control","volume":"133","author":"Zhuang","year":"2021","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.pnpbp.2024.111176_bb1755","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.pediatrneurol.2020.06.011","article-title":"Syndromic autism revisited: review of the literature and lessons learned","volume":"114","author":"Ziats","year":"2021","journal-title":"Pediatr. Neurol."},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111176_bb1760","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13229-021-00447-5","article-title":"Randomized controlled trial of sulforaphane and metabolite discovery in children with Autism Spectrum Disorder [published correction appears in Mol Autism. 2021 Jun 16;12(1):44]","volume":"12","author":"Zimmerman","year":"2021","journal-title":"Mol Autism."}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584624002446?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584624002446?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T19:32:02Z","timestamp":1762284722000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584624002446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":357,"alternative-id":["S0278584624002446"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2024.111176","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The pediatric psychopharmacology of autism spectrum disorder: A systematic review - Part II: The future","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2024.111176","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"111176"}}